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Acute	  Kidney	  Injury	  (AKI)	  is	  a	  prevalent	  and	  significant	  problem	  whose	  primary	  
treatment	  is	  supportive	  care.	  Ischemic	  preconditioning	  is	  a	  strategy	  used	  to	  protect	  
organs	  from	  ischemic	  injury	  via	  a	  prior	  injury.	  Ischemic	  preconditioning	  in	  the	  kidneys	  
has	  been	  shown	  to	  confer	  protection	  onto	  kidneys	  from	  subsequent	  ischemic	  insults	  
with	  attenuated	  serum	  creatinine	  values	  in	  treated	  rats.	  In	  the	  preconditioned	  kidneys,	  
the	  enzyme	  IDH2	  was	  discovered	  to	  be	  upregulated	  in	  the	  mitochondria.	  Hydrodynamic	  
fluid	  delivery	  to	  the	  kidney	  was	  found	  to	  be	  a	  viable	  technique	  for	  delivering	  this	  gene	  to	  
the	  kidney,	  resulting	  in	  artificially	  upregulated	  expression	  of	  IDH2.	  Via	  a	  two-­‐pronged	  
effort	  to	  discern	  the	  functional	  significance	  of	  ischemic	  preconditioning	  and	  
hydrodynamic	  IDH2	  fluid	  injections,	  we	  performed	  mitochondrial	  oxygen	  respiration	  
assays	  on	  both	  preconditioned	  and	  injected	  kidneys.	  We	  found	  that	  renal	  ischemic	  
preconditioning	  resulted	  in	  no	  significant	  difference	  between	  sham	  and	  preconditioned,	  
subsequently	  injured	  kidneys,	  which	  is	  similar	  to	  the	  results	  from	  the	  serum	  creatinine	  
studies.	  Hydrodynamically	  IDH2-­‐injected,	  and	  subsequently	  injured	  kidneys	  respire	  
significantly	  better	  than	  vehicle	  injected,	  and	  subsequently	  injured	  kidneys,	  which	  
shows	  that	  hydrodynamic	  injections	  of	  IDH2	  protects	  kidneys	  against	  injury,	  and	  
partially	  mimics	  the	  effects	  of	  preconditioning.	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1.1.1 AKI:	  A	  Significant	  and	  Common	  Clinical	  Problem	  
Acute	  kidney	  injury	  (AKI)	  refers	  to	  a	  common	  and	  significant	  clinical	  syndrome	  
that	  is	  characterized	  by	  a	  rapid	  decrease	  in	  renal	  function,	  leading	  to	  an	  accumulation	  of	  
blood	  urea	  nitrogen,	  creatinine	  and	  other	  waste	  products.	  The	  term	  AKI	  has	  replaced	  
acute	  renal	  failure	  (ARF)	  used	  to	  in	  older	  literature	  to	  describe	  a	  spectrum	  of	  clinical	  
manifestations	  that	  presents	  acutely	  in	  the	  kidney,	  with	  accompanying	  increasing	  
mortality	  and	  worse	  prognosis	  associated	  with	  increasing	  serum	  creatinine	  values.	  AKI	  is	  
common	  in	  hospital	  patients,	  especially	  in	  critically	  ill	  patients,	  whose	  AKI	  is	  often	  
secondary	  to	  extrarenal	  events[1].	  There	  are	  more	  than	  5000	  cases	  per	  million	  people	  
per	  year	  for	  non-­‐dialysis	  requiring	  AKI	  and	  295	  cases	  per	  million	  for	  dialysis-­‐requiring	  
manifestations[2].	  AKI	  is	  especially	  common	  in	  critically	  ill	  patients	  with	  an	  occurrence	  of	  
more	  than	  36%	  after	  admission	  to	  an	  ICU,	  with	  septic	  AKI	  prevalent	  24	  hours	  after	  
admission[3,	  4].	  	  
	  
AKI	  is	  a	  great	  healthcare	  concern	  because	  of	  its	  high	  prevalence	  and	  substantial	  
treatment	  cost.	  In	  2011,	  AKI	  costs	  about	  $4.7	  billion	  for	  approximately	  498,000	  hospital	  
stays[5].	  Even	  with	  new	  prevention	  and	  support	  strategies,	  AKI	  has	  high	  morbidity	  and	  
mortality	  rates.	  The	  ICU	  population	  is	  at	  immense	  risk	  due	  to	  multi-­‐organ	  disease	  and	  
sepsis[3,	  6,	  7].	  There	  are	  no	  direct	  and	  effective	  targeted	  therapies	  for	  AKI	  and	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treatment	  is	  mostly	  supportive.	  However,	  new	  diagnostic	  techniques	  in	  the	  form	  of	  
renal	  biomarkers	  may	  help	  with	  early	  detection	  and	  accelerated	  recovery.	  Patients	  with	  
past	  history	  of	  AKI	  are	  also	  at	  increased	  risk	  of	  chronic	  kidney	  disease[1].	  	  
	  
	  
1.1.2 Causes	  of	  AKI	  
AKI	  can	  be	  caused	  by	  sepsis,	  cardiac	  shock,	  disease,	  crush	  injury,	  contrast	  agents	  
and	  antibiotics.[8-­‐14].	  The	  mechanism	  of	  injury	  by	  these	  agents	  still	  remains	  to	  be	  
elucidated.	  From	  a	  pathogenic	  standpoint,	  the	  causes	  of	  AKI	  are	  conventionally	  grouped	  
into	  prerenal,	  intrinsic	  and	  postrenal[15].	  	  
	  
Prerenal	  AKI	  is	  the	  most	  common	  cause	  of	  AKI	  in	  hospital	  inpatients	  and	  critically	  
ill	  patients,	  with	  higher	  prevalence	  in	  developed	  countries[16].	  Prerenal	  AKI	  occurs	  
when	  there	  is	  renal	  ischemia,	  a	  lack	  of	  blood	  flow	  to	  the	  kidney.	  Renal	  artery	  
stenosis[17,	  18],	  renal	  vein	  thrombosis	  [19],	  low	  blood	  volume,	  low	  blood	  pressure,	  
heart	  failure,	  liver	  cirrhosis,	  exposure	  to	  substances	  harmful	  to	  the	  kidney,	  inflammatory	  
process	  in	  the	  kidney	  are	  all	  potential	  causes	  of	  prerenal	  AKI[20].	  	  
	  
Intrinsic	  AKI	  occurs	  when	  there	  is	  injury	  intrinsic	  to	  the	  kidney.	  The	  injury	  can	  be	  
further	  categorized	  based	  on	  the	  structure	  affected.	  There	  can	  be	  damage	  to	  the	  
glomeruli	  resulting	  in	  glomerulonephritis,	  tubules	  resulting	  in	  acute	  tubular	  necrosis	  
(ATN)	  or	  renal	  interstitium	  resulting	  in	  acute	  interstitial	  nephritis[21].	  	  
	  
Postrenal	  AKI	  occurs	  when	  there	  is	  obstruction	  in	  the	  excretion	  of	  urine.	  This	  
may	  be	  cause	  by	  urinary	  tract	  obstruction,	  prostate	  problems,	  kidney	  stones,	  obstructed	  
urinary	  catheter	  or	  tumor	  masses	  in	  the	  bladder	  or	  urethra.	  
	  
Some	  causes	  of	  AKI	  are	  more	  frequent	  in	  certain	  geographical	  locations.	  For	  
example,	  in	  developing	  countries,	  hypervolemia	  secondary	  to	  diarrhea	  is	  a	  prevalent	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cause,	  whereas	  in	  developed	  countries,	  hypervolemia	  secondary	  to	  open	  heart	  surgery	  
is	  more	  common.	  	  Also,	  there	  are	  also	  differences	  within	  a	  country,	  where	  certain	  




1.1.3 Classification	  of	  AKI	  
AKI	  has	  recently	  replaced	  the	  term	  acute	  renal	  failure	  (ARF)	  to	  better	  depict	  the	  
spectrum	  of	  AKI	  by	  the	  Acute	  Dialysis	  Quality	  Initiative.	  The	  system	  RIFLE	  (risk,	  injury,	  
failure,	  loss,	  end	  stage)	  criteria	  was	  developed	  and	  supported	  by	  the	  Acute	  Kidney	  
Network[4,	  23-­‐25].	  The	  system	  criteria	  has	  been	  tried	  and	  tested	  in	  thousands	  of	  
patients.	  	  
	  
Table	  1:	  RIFLE	  Criteria	  for	  Acute	  Kidney	  Injury	  [4]	  
	   GFR	  Criteria	   Urine	  Output	  Criteria	  
Risk	   1.5	  Fold	  increase	  in	  sCR	  or	  
GFR	  decrease	  >25%	  
UO	  <0.5mL/kg/h	  for	  6h	  
Injury	   2	  Fold	  increase	  in	  sCR	  or	  
GFR	  decrease	  >50%	  
UO	  <0.5mL/kg/h	  for	  12h	  
Failure	   3	  Fold	  increase	  in	  sCR	  or	  
GFR	  decrease	  of	  >75%,	  
sCR>4mg/dl	  or	  acute	  rise	  in	  
sCR>0.5mg/dl	  
UO<0.3mL/kg/h	  for	  24	  h	  or	  
anuria	  for	  12h	  
Loss	   Complete	  Loss	  of	  kidney	  function	  >4	  weeks	  
ESKD	   End-­‐stage	  kidney	  disease	  (>3	  months)	  
	  
The	  RIFLE	  criteria	  show	  the	  parameters	  for	  classifying	  a	  patient’s	  condition	  from	  class	  R	  
(risk)	  to	  class	  F	  (failure).	  Class	  R	  has	  a	  high	  sensitivity	  and	  class	  F	  has	  a	  high	  specificity	  for	  
AKI.	  sCR	  –	  serum	  creatinine	  concentration.	  UO	  –	  urine	  output.	  GFR	  –	  glomerular	  
filtration	  rate.	  ESKD	  –	  end-­‐stage	  kidney	  disease.	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1.1.4 Signs	  and	  Symptoms	  of	  AKI	  
Since	  the	  kidney	  functions	  to	  maintain	  homeostasis	  via	  excretion	  of	  waste	  
products	  of	  metabolism	  as	  well	  as	  other	  regulatory	  functions,	  the	  symptoms	  of	  AKI	  are	  
caused	  by	  the	  accumulation	  of	  urea	  and	  other	  nitrogenous	  waste	  products	  that	  cannot	  
be	  properly	  excreted.	  Symptoms	  include	  fatigue,	  loss	  of	  appetite,	  headache	  and	  nausea.	  
There	  can	  also	  be	  a	  significant	  increase	  in	  serum	  potassium	  that	  disrupts	  cardiac	  
function.	  Due	  to	  inability	  to	  excrete	  sufficient	  fluid	  from	  the	  body,	  fluid	  balance	  is	  
affected,	  causing	  edema,	  or	  the	  accumulation	  of	  fluid,	  particularly	  in	  the	  lungs	  and	  distal	  
regions	  of	  the	  limbs[26-­‐28].	  	  
	  
AKI	  is	  diagnosed	  by	  simple	  laboratory	  tests,	  with	  increases	  in	  blood	  urea	  nitrogen	  
and	  serum	  creatinine[29].	  Observations	  of	  oliguria,	  or	  insufficient	  production	  of	  urine,	  
warrant	  a	  diagnosis	  of	  AKI	  as	  well.	  However,	  these	  clinical	  parameters	  are	  relatively	  late	  
markers	  in	  the	  injury	  process,	  as	  AKI	  is	  relatively	  asymptomatic	  till	  late	  in	  the	  injury	  
process,	  and	  recent	  efforts	  are	  made	  to	  identify	  new	  biomarkers	  and	  tests	  that	  would	  
allow	  for	  much	  earlier	  detection[30].	  
	  
In	  various	  studies,	  investigators	  have	  identified	  novel	  biomarkers	  for	  identifying	  
AKI,	  and	  the	  concentrations	  of	  these	  biomarkers	  seem	  to	  change	  earlier	  than	  serum	  
creatinine	  (sCR)	  concentrations	  and	  can	  possibly	  allow	  for	  earlier	  detection	  in	  order	  to	  
administer	  adequate	  therapy.	  These	  new	  biomarkers	  may	  be	  able	  to	  warn	  of	  impending	  
AKI	  earlier.	  Different	  biomarkers	  also	  show	  different	  aspects	  of	  renal	  segment	  injury.	  
Cystatin	  C	  concentrations	  seemed	  to	  predict	  changes	  in	  glomerular	  filtration	  rate	  and	  
neutrophil	  gelatinase-­‐associated	  lipocalin	  (NGAL)	  levels	  are	  shown	  to	  associate	  with	  
tubular	  stress	  and	  injury[31-­‐40].	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1.1.5 Present	  Management	  of	  AKI	  
Current	  treatment	  of	  AKI	  is	  primarily	  focused	  on	  supportive	  care.	  Therefore,	  
improved	  treatment	  and	  management	  is	  dependent	  on	  a	  better	  understanding	  of	  its	  
underlying	  causes.	  Currently,	  management	  of	  AKI	  is	  to	  remove	  the	  primary	  cause	  (e.g.	  
mediating	  cardiac	  output	  or	  treating	  sepsis[13,	  18])	  and	  utilize	  supportive	  measures	  to	  
maintain	  homeostasis	  while	  allowing	  the	  kidney	  to	  recover.	  There	  is	  supporting	  
evidence	  for	  starting	  general	  nutritional	  support	  of	  adequate	  calories,	  vitamins,	  trace	  
elements	  and	  protein	  early,	  and	  specific	  renal	  nutritional	  solutions	  are	  not	  
necessary[41].	  	  
	  
In	  patients	  with	  hyperkalemia,	  there	  are	  the	  options	  of	  administering	  insulin,	  
dextrose,	  bicarbonate	  (if	  there	  is	  acidosis	  as	  well),	  nebulized	  salbutamol	  or	  calcium	  
gluconate	  solution.	  These	  treatments	  utilize	  different	  ways	  to	  induce	  cellular	  uptake	  of	  
potassium:	  insulin	  administered	  with	  glucose	  facilitates	  the	  uptake	  of	  glucose	  into	  the	  
cell,	  and	  potassium	  follows	  as	  such;	  bicarbonate	  increases	  the	  extracellular	  pH,	  which	  
results	  in	  cellular	  uptake	  of	  potassium	  as	  well;	  calcium	  gluconate	  stabilizes	  the	  cardiac	  
cell	  membrane	  against	  the	  excitability	  of	  the	  hyperkalemic	  environment;	  and	  
sabultamol	  indirectly	  stimulates	  the	  NaK	  ATP	  pump	  via	  adenylate	  cyclase	  to	  increase	  
potassium	  uptake	  into	  the	  cell.	  Drug	  therapy	  should	  be	  modified	  to	  take	  in	  to	  
consideration	  the	  decreased	  ability	  of	  the	  kidney	  to	  clear	  the	  substance.	  If	  there	  is	  fluid	  
overload,	  the	  use	  of	  loop	  diuretics	  in	  patients	  with	  polyuria	  is	  an	  option.	  There	  are	  no	  
specific	  recommendations	  for	  fluid	  management,	  but	  renal	  replacement	  therapy	  is	  
recommended	  at	  an	  early	  stage	  for	  critically	  ill	  patients	  [1].	  	  
	  
In	  sum,	  there	  are	  no	  targeted	  therapies	  that	  can	  lessen	  AKI	  or	  speed	  recovery.	  
Fluid,	  electrolyte	  and	  acid-­‐based	  balance	  management	  is	  mainly	  supportive	  treatment	  
option	  and	  beyond	  these	  measures,	  in	  the	  long	  term,	  kidney	  transplant	  is	  an	  option	  for	  
patients	  suffering	  from	  irreversible	  kidney	  injury	  and	  failure[42].	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1.1.6 Structure	  and	  Organization	  of	  Function	  in	  the	  Kidney	  
In	  order	  to	  understand	  function	  and	  subsequently	  dysfunction	  in	  AKI,	  it	  is	  
important	  to	  understand	  the	  underlying	  structure	  and	  organization	  of	  function	  in	  the	  
kidney.	  The	  unique	  spatial	  separation	  of	  various	  transporters,	  beset	  in	  various	  
environments	  results	  in	  the	  filtration	  machine	  that	  is	  the	  kidney.	  Blood	  is	  first	  filtered	  
through	  the	  glomerulus	  into	  the	  Bowman’s	  capsule	  before	  entering	  the	  proximal	  tubule.	  
Proximal	  tubules	  are	  the	  workhorses	  of	  the	  nephron	  in	  that	  they	  reabsorb	  glucose,	  
amino	  acids,	  bicarbonate,	  and	  water	  back	  into	  the	  cells	  to	  reconstitute	  blood.	  The	  
driving	  force	  is	  secondary	  active	  transport,	  requiring	  a	  high	  concentration	  of	  
mitochondria	  in	  order	  to	  power	  these	  processes.	  The	  proximal	  tubules	  are	  then	  
followed	  by	  the	  loops	  of	  Henle,	  which	  are	  situated	  in	  the	  medulla	  of	  the	  kidney.	  The	  
loop	  of	  Henle	  ascends	  to	  the	  distal	  convoluted	  tubules,	  which	  are	  situated	  in	  the	  cortex	  
along	  with	  the	  proximal	  convoluted	  tubule.	  The	  cortex	  region	  of	  the	  kidney	  has	  a	  dense	  
capillary	  network	  and	  a	  high	  effective	  blood	  flow[43].	  	  
	  
Scanning	  electron	  microscopy	  and	  transmission	  electron	  microscopy	  of	  kidney	  
sections	  has	  been	  useful	  in	  visualizing	  the	  unique	  structures	  of	  kidney	  tissues.	  In	  the	  
proximal	  tubule,	  the	  apical	  regions	  of	  cells	  appear	  rounded	  and	  interlocked,	  similar	  to	  a	  
ball	  and	  socket	  type	  of	  interlocking.	  There	  is	  a	  high	  density	  of	  mitochondria	  visualized	  
within	  the	  proximal	  tubule	  cells.	  	  The	  lumens	  are	  framed	  by	  the	  brush	  border,	  which	  
may	  appear	  as	  craters	  on	  the	  EM	  sections.	  Primary	  cilia	  are	  projected	  above	  the	  brush	  
border	  into	  the	  lumen.	  Vessels	  are	  also	  frequently	  identified	  in	  a	  proximal	  tubule	  
section.	  The	  distal	  tubule	  is	  difficult	  to	  identify,	  but	  typically	  the	  lumen	  contains	  a	  short	  
microvilli	  of	  irregular	  shape	  and	  lacks	  a	  brush	  border[44].	  	  
	  
An	  ischemic	  event	  results	  in	  significant	  alterations	  in	  morphology	  of	  the	  normal	  
renal	  tissue,	  namely	  disruption	  and	  loss	  of	  proximal	  tubule	  brush	  border,	  sloughing	  off	  
of	  tubule	  cells,	  proximal	  tubular	  dilation	  and	  distal	  tubular	  casts,	  and	  areas	  of	  cellular	  
regeneration[15,	  45,	  46].	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1.1.7 Pathophysiology	  and	  Systemic	  Responses	  to	  AKI	  
The	  pathophysiology	  of	  prerenal	  AKI	  has	  been	  studied	  in	  animals[47,	  48].	  In	  
studies	  occluding	  the	  blood	  flow	  in	  the	  renal	  artery,	  there	  are	  many	  pathways	  that	  are	  
implicated	  in	  the	  system	  of	  organ	  injury[49,	  50].	  Coagulation	  is	  activated[51],	  leucocytes	  
are	  recruited[52],	  the	  endothelium	  is	  injured[53],	  adhesion	  molecules	  are	  
expressed[54],	  cytokines	  are	  release[55],	  toll-­‐like	  receptors	  are	  induced[56],	  intrarenal	  
vasoconstrictor	  pathways	  are	  activated[57]	  and	  apoptosis	  is	  induced[49,	  50].	  Tubular	  
cells	  lose	  or	  inverse	  their	  polarity[58]	  and	  lose	  adhesion	  to	  the	  basement	  membrane[49,	  
50].	  
	  
Prerenal	  mechanisms	  are	  one	  of	  the	  most	  common	  causes	  of	  AKI.	  Due	  to	  the	  
high	  volume	  of	  blood	  flow	  and	  the	  high	  level	  of	  metabolic	  activity	  required	  to	  process	  
the	  volume	  of	  blood,	  the	  kidney	  is	  extremely	  sensitive	  to	  injury	  and	  toxins.	  In	  a	  renal	  
ischemia/reperfusion	  injury	  (IRI),	  a	  lack	  of	  oxygen	  delivery	  and	  nutrients	  to	  the	  cells	  of	  
the	  kidney	  is	  combined	  with	  a	  failure	  to	  remove	  waste	  products[59-­‐61].	  Proximal	  
tubules	  are	  especially	  sensitive	  to	  hypoxia	  because	  they	  principally	  depend	  on	  oxidative	  
catabolism,	  whereas	  distal	  tubular	  segments	  and	  medullary	  thick	  ascending	  limbs	  can	  
utilize	  glycolysis	  to	  endure	  severe	  hypoxia[62].	  	  
	  
Chief	  regulators	  of	  renal	  regional	  perfusion	  and	  tubular	  transport	  activity	  include	  
nitric	  oxide	  (NO),	  adenosine,	  dopamine	  and	  vasodilator	  prostaglandins.	  NO,	  dopamine	  
and	  PGE2	  enhance	  blood	  flow	  and	  suppress	  transport	  and	  oxygen	  consumption	  while	  
adenosine	  and	  other	  vasoconstrictors	  reduce	  cortical	  blood	  flow	  and	  glomerular	  
filtration	  rate	  (GFR),	  leading	  to	  decreases	  in	  tubular	  transport,	  oxygen	  consumption	  and	  
downstream	  solute	  delivery.[63,	  64]	  
	  
Morphologically,	  acute	  sublethal	  changes	  in	  rat	  models	  include	  the	  loss	  of	  brush	  
border,	  cell	  and	  mitochondrial	  swelling,	  cytoplasmic	  vacuolization	  and	  nuclear	  
pyknosis[65].	  During	  a	  response	  to	  ischemia,	  epithelial	  cells	  lose	  normal	  cytoskeletal	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organization	  and	  cell	  polarity.	  In	  the	  kidney,	  integrins	  with	  B1	  subunit	  are	  the	  most	  
common	  and	  localize	  to	  basal	  surfaces	  of	  tubular	  epithelia,	  where	  they	  interact	  with	  the	  
extracellular	  matrix	  of	  basement	  membrane.	  In	  one	  rat	  study	  with	  a	  40min	  unilateral	  
ischemia,	  B1	  integrins	  appear	  on	  lateral	  borders	  in	  the	  epithelial	  cells	  of	  the	  S3	  segment	  
but	  not	  on	  the	  apical	  surfaces	  immediately	  after	  reperfusion.	  As	  reperfusion	  continues,	  
epithelial	  cells	  attached	  to	  the	  basement	  membrane	  localize	  B1	  to	  the	  basal	  surfaces	  
while	  the	  polarity	  of	  other	  marker	  proteins	  are	  lost.	  Sloughing	  off	  of	  cells	  in	  the	  lumen	  is	  
a	  common	  phenomenon	  during	  injury	  and	  B1	  integrins	  were	  not	  detected	  on	  exfoliated	  
cells,	  indicating	  that	  B1	  integrin	  distribution	  is	  dramatically	  changed	  during	  ischemic	  
injury[58].	  	  Further	  injury	  may	  lead	  to	  cell	  death	  by	  either	  necrosis	  or	  apoptosis[66,	  67].	  
Also,	  in	  response	  to	  injury,	  the	  epithelium	  induces	  an	  inflammatory	  reaction,	  activating	  
cytokines	  and	  vasoactive	  mediators,	  which	  exacerbate	  vasoconstriction	  and	  the	  
inflammatory	  process.	  	  
	  
Endothelial	  cells	  are	  also	  involved	  in	  the	  kidney’s	  response	  to	  AKI.	  First,	  damaged	  
endothelial	  cells	  contribute	  to	  vasoconstriction	  by	  decreasing	  production	  of	  nitric	  oxide	  
and	  other	  vasodilators.	  Small	  vessels	  can	  also	  be	  occluded	  due	  to	  the	  coagulation	  
triggered	  by	  the	  immune	  response	  and	  lead	  to	  regional	  ischemia[53].	  Second,	  damage	  
to	  the	  endothelial	  cell	  layer	  increases	  the	  permeability	  of	  the	  microvascular	  barrier	  and	  
reduces	  the	  number	  of	  microvessels	  in	  the	  outer	  medulla,	  which	  results	  in	  chronic	  
hypoxia	  even	  when	  the	  injury	  is	  resolved[68,	  69].	  Chronic	  hypoxia	  results	  when	  tissues	  
are	  gradually	  deprived	  of	  oxygen,	  leading	  to	  progressive	  fibrosis,	  further	  altering	  the	  
structure	  and	  function	  of	  the	  kidney.	  There	  is	  less	  delivery	  of	  oxygen	  and	  nutrients,	  
further	  epithelial	  cell	  injury	  and	  further	  fibrosis,	  leading	  to	  a	  vicious	  cycle	  of	  injury[70,	  
71].	  	  
	  
There	  are	  both	  innate	  and	  adaptive	  immune	  responses	  in	  ischemic	  injury.	  The	  
innate	  immune	  response	  is	  seen	  in	  an	  early	  response	  to	  injury	  in	  a	  non-­‐antigen-­‐specific	  
mode[72].	  Damaged	  tissue	  releases	  endogenous	  ligands,	  which	  upregulate	  Toll-­‐Like	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receptors	  (TLRs),	  which	  activates	  mature	  dendritic	  cells	  (DCs)[56,	  73,	  74].	  DCs	  then	  in	  
turn	  activate	  T-­‐lymphocytes,	  initiating	  an	  adaptive	  immune	  response.	  Injured	  tubular	  
epithelial	  cells	  also	  express	  adhesion	  molecules	  [75]	  and	  other	  ligands	  for	  T	  cells	  in	  
addition	  to	  TLRs[76],	  and	  these	  activate	  immune	  cells,	  leading	  to	  further	  inflammation.	  
Cytokines	  and	  chemokines	  are	  also	  released	  by	  the	  epithelium	  to	  recruit	  more	  immune	  
cells[77].	  	  Various	  immune	  cells	  including	  monocytes/macrophages,	  DCs,	  and	  T	  cells,	  
releases	  factors	  that	  allows	  for	  increased	  vascular	  permeability,	  thus	  impairing	  tubular	  
epithelial	  and	  endothelial	  cells,	  further	  worsening	  the	  injury[78].	  	  
	  
The	  cellular	  adaptations	  and	  responses	  to	  kidney	  injury	  and	  repair	  are	  still	  not	  
yet	  fully	  understood	  and	  elucidated.	  Better	  understanding	  and	  further	  research	  is	  
needed	  to	  improve	  therapies	  to	  prevent	  renal	  injury,	  mediate	  the	  recovery	  process	  in	  
the	  event	  of	  an	  injury	  and	  minimize	  the	  effects	  of	  chronic	  kidney	  disease.	  	  
	  
During	  AKI,	  the	  sympathetic	  system	  and	  neurohormonal	  responses	  are	  activated.	  
The	  renin-­‐angiotensin-­‐aldosterone	  system,	  renal	  sympathetic	  system	  and	  
tubuloglomerular	  feedback	  systems	  are	  activated,	  events	  that	  signal	  a	  general	  body	  
response	  to	  AKI[13,	  79,	  80].	  Direct	  infusions	  of	  norepinephrine	  into	  the	  renal	  artery	  
resulted	  in	  prolonged	  reductions	  in	  blood	  flow	  to	  the	  kidney	  similar	  to	  AKI[81].	  
Increased	  sympathetic	  innervation	  also	  results	  in	  the	  activation	  of	  the	  renin-­‐
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1.2.1 Ischemic	  Preconditioning	  
Ischemic	  preconditioning	  (IP)	  is	  a	  phenomenon	  first	  described	  by	  Murry	  and	  
colleagues	  on	  the	  dog	  heart	  in	  1986[83].	  IP	  refers	  to	  a	  sublethal	  ischemia/reperfusion	  
injury	  (IRI)	  to	  an	  organ	  that	  allows	  the	  organ	  to	  be	  more	  resistant	  to	  subsequent	  bouts	  
of	  injury.	  The	  protection	  conferred	  by	  IRI	  was	  also	  demonstrated	  in	  other	  animal	  models	  
including	  rabbits,	  guinea	  pigs	  and	  rats	  [84,	  85]	  as	  well	  as	  different	  organs	  including	  the	  
heart[85],	  liver[86],	  lung[87]	  and	  kidney[88].	  	  
	  
Although	  IP	  was	  first	  described	  in	  the	  heart	  due	  to	  its	  relationship	  to	  myocardial	  
infarctions,	  there	  is	  now	  substantial	  research	  supporting	  the	  finding	  that	  IP	  can	  confer	  
protection	  to	  the	  kidney	  against	  subsequent	  bouts	  of	  injury[89].	  Kidneys	  are	  extremely	  
susceptible	  to	  ischemia/reperfusion	  due	  to	  its	  extensive	  blood	  flow	  and	  workload,	  and	  
there	  are	  extensive	  cellular	  responses	  to	  resulting	  hypoxia	  and	  repair	  mechanisms[62].	  
Animal	  models	  have	  confirmed	  both	  local	  and	  distant	  preconditioning	  effects	  in	  the	  
protection	  of	  the	  kidneys[90,	  91].	  	  
	  
Meta-­‐analysis	  has	  confirmed	  that	  IP	  can	  reduce	  the	  parameters	  of	  injury	  in	  
decreased	  serum	  creatinine	  and	  blood	  urea	  nitrogen,	  as	  well	  as	  structural	  alterations	  as	  
observed	  by	  histology	  after	  IRI	  compared	  to	  controls.	  This	  suggests	  that	  IP	  effectively	  
alleviates	  renal	  damage	  after	  IRI,	  however	  the	  mechanism	  to	  the	  preconditioning	  
phenomenon	  is	  yet	  to	  be	  understood.	  Thus,	  it	  is	  important	  to	  understand	  the	  
mechanisms	  involved	  in	  ischemic	  preconditioning	  in	  the	  kidney	  in	  order	  to	  devise	  
therapy	  that	  mimics	  the	  protective	  mechanisms	  of	  IP,	  as	  IP	  is	  not	  a	  possible	  clinical	  
approach.	  Currently,	  there	  is	  evidence	  that	  supports	  two	  theories	  for	  the	  protective	  
effect	  of	  IP	  in	  other	  organs:	  the	  opening	  of	  mitochondrial	  ATP-­‐sensitive	  potassium	  
(mitoKATP)	  channels	  and	  the	  regulatory	  functions	  of	  protein	  kinase	  C	  (PKC)[92,	  93].	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In	  a	  cellular	  energy	  crisis	  similar	  to	  an	  IP	  event,	  mitoKATP	  channels	  open	  and	  
close	  in	  order	  to	  restore	  proper	  membrane	  potential,	  internal	  Ca2+	  concentration	  and	  
the	  degree	  of	  membrane	  swelling.	  The	  maintenance	  of	  membrane	  potential	  allows	  the	  
mitochondria	  to	  maintain	  the	  proton	  gradient	  for	  mitochondria	  ATP	  synthesis	  in	  order	  
to	  meet	  the	  energy	  demands	  of	  the	  cells[94].	  There	  are	  three	  major	  hypotheses	  for	  the	  
mechanism	  of	  protection	  via	  the	  mitoKATP	  channel.	  First,	  mitoKATP	  channel	  openings	  may	  
attenuate	  Ca2+	  ion	  accumulation,	  through	  a	  partial	  depolarization	  in	  response	  to	  the	  
opening	  of	  the	  channel,	  during	  ischemia	  and	  studies	  that	  induced	  a	  decrease	  in	  
mitochondrial	  calcium	  ion	  loading	  under	  anoxic	  conditions	  resulted	  in	  protection	  of	  
isolated	  mitochondria[95].	  	  
	  
The	  second	  hypothesis	  points	  to	  mitochondrial	  matrix	  swelling	  and	  changes	  in	  
ATP	  synthesis	  as	  a	  potential	  mechanism	  behind	  the	  protection	  of	  mitochondria	  function,	  
as	  mitochondria	  swelling	  is	  an	  indication	  of	  mitoKATP	  channels	  opening.	  In	  a	  study	  by	  Lim	  
et	  al.,	  preconditioning	  increased	  matrix	  volume	  by	  58%	  with	  preconditioning	  in	  isolated	  
mitochondria[96].	  It	  is	  proposed	  that	  mitochondria	  swelling	  allows	  the	  inner	  and	  outer	  
mitochondrial	  membranes	  to	  come	  closer	  together,	  so	  that	  the	  membrane	  and	  channel	  
proteins	  on	  both	  membranes	  can	  optimize	  contact,	  resulting	  in	  increase	  in	  ADP	  
transport	  and	  ATP	  synthesis[97].	  	  
	  
A	  third	  hypothesis	  points	  to	  the	  role	  that	  mitoKATP	  channel	  plays	  in	  apoptosis.	  
Studies	  involving	  diazoxide	  pretreatment	  of	  myocardial	  mitochondria	  resulted	  in	  
reduced	  markers	  of	  apoptosis	  from	  IRI	  and	  mitoKATP	  protects	  against	  the	  early	  stages	  of	  
apoptosis	  and	  protected	  the	  integrity	  of	  mitochondria[98-­‐100].	  	  
	  
Also,	  MitoKATP	  is	  believed	  to	  be	  regulated	  by	  several	  pathways	  via	  PKC[101].	  There	  
are	  theories	  outlining	  the	  possible	  mechanisms,	  including	  controlling	  the	  release	  of	  
oxygen	  radicals	  and	  levels	  of	  Pcl-­‐2	  proteins,	  a	  major	  regulator	  of	  apoptosis[102].	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1.3.1 The	  Function	  and	  Structure	  of	  Mitochondria	  
The	  mitochondria	  play	  essential	  roles	  in	  cell	  survival,	  both	  in	  the	  form	  of	  ATP	  
synthesis	  and	  the	  maintenance	  of	  calcium	  homeostasis.	  The	  mitochondrion	  functions	  as	  
an	  energy	  generator	  for	  the	  cell,	  producing	  most	  of	  the	  cell’s	  supply	  of	  ATP,	  but	  is	  also	  
involved	  in	  signaling,	  cell	  growth	  and	  cell	  death[103].	  The	  mitochondria	  play	  important	  
roles	  in	  metabolism,	  metal	  ion	  homeostasis	  and	  are	  major	  sources	  and	  regulators	  of	  
reactive	  oxygen	  species	  (ROS)[104].	  	  
	  
The	  mitochondrion	  is	  unique	  in	  terms	  of	  its	  structure	  in	  the	  cell;	  it	  consists	  of	  an	  
outer	  and	  inner	  membrane.	  The	  two	  membranes	  differ	  in	  permeability	  and	  composition,	  
and	  help	  establish	  a	  unique	  environment	  between	  the	  membranes	  that	  allows	  for	  ATP	  
synthesis.	  The	  outer	  membrane	  is	  embedded	  with	  pores	  that	  allows	  target	  proteins	  and	  
ions	  to	  pass	  while	  the	  inner	  membrane	  is	  less	  permeable	  to	  ions	  and	  smaller	  proteins,	  
and	  embedded	  with	  proteins	  involved	  in	  the	  electron	  transport	  chain	  (ETC)	  and	  ATP	  
synthesis.	  The	  inner	  membrane	  encloses	  the	  mitochondrial	  matrix,	  which	  contains	  
enzymes	  involved	  in	  the	  citric	  acid	  cycle,	  the	  pyruvate	  dehydrogenase	  complex,	  fatty	  
acid	  oxidation	  enzymes,	  amino	  acid	  oxidation	  enzymes	  and	  other	  soluble	  metabolic	  
intermediates[105].	  	  
	  
In	  the	  citric	  acid	  cycle	  (Figure	  1),	  pyruvate	  is	  imported	  into	  the	  mitochondrial	  
matrix	  through	  a	  pyruvate	  protein	  carrier.	  Pyruvate	  first	  undergoes	  oxidative	  
decarboxylation,	  catalyzed	  by	  pyruvate	  dehydrogenase	  complex	  (PDH)	  to	  produce	  acetyl	  
CoA,	  where	  electrons	  are	  withdrawn	  to	  make	  ATP	  and	  carbon	  dioxide	  is	  released.	  Next,	  
acetyl	  CoA	  enters	  the	  citric	  acid	  cycle	  when	  it	  combines	  with	  oxaloacetate	  to	  generate	  
citrate	  via	  thioester	  hydrolysis	  with	  the	  enzyme	  citrate	  synthase.	  Citrate	  is	  converted	  in	  
the	  next	  step	  into	  isocitrate,	  a	  better	  substrate	  for	  oxidation	  via	  aconitase.	  Isocitrate	  is	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then	  oxidized	  by	  isocitrate	  dehydrogenase	  in	  an	  oxidative	  decarboxylation	  reaction	  into	  
alpha-­‐ketoglutarate,	  a	  5-­‐carbon	  intermediate,	  producing	  NADH	  and	  is	  fed	  into	  complex	  I	  
of	  the	  electron	  transport	  chain	  (Figure	  2).	  Alpha-­‐ketoglutarate	  is	  further	  undergoes	  
oxidative	  decarboxylation	  to	  become	  succinyl-­‐CoA	  via	  the	  alpha-­‐ketoglutarate	  
dehydrogenase	  complex.	  Succinyl-­‐CoA	  then	  undergoes	  thioester	  cleavage	  to	  generate	  
GTP	  and	  succinate.	  Succinate	  is	  then	  oxidized	  by	  succinate	  dehydrogenase	  to	  fumarate,	  
with	  electrons	  accepted	  by	  FAD,	  FADH2	  is	  subsequently	  fed	  into	  complex	  II	  of	  the	  
electron	  transport	  chain	  (Figure	  2).	  	  Succinate	  dehydrogenase	  is	  the	  only	  enzyme	  of	  the	  
citric	  acid	  cycle	  not	  found	  in	  the	  matrix,	  but	  tightly	  bound	  to	  the	  inner	  mitochondrial	  
membrane	  in	  order	  for	  electrons	  to	  be	  passed	  directly	  from	  FADH2	  to	  Coenzyme	  Q	  in	  
the	  electron	  transport	  chain	  (ETC)	  [105].	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Figure	  1:	  The	  Citric	  Acid	  Cycle	  (TCA)	  [105]	  
	  
During	  the	  Citric	  Acid	  cycle,	  electrons	  are	  harvested	  to	  reduce	  cofactors	  flavin	  
adenine	  dinucleotide	  (FADH2)	  and	  nicotinamide	  adenine	  dinucleotide	  (NADH),	  and	  these	  
electrons	  enter	  the	  electron	  transport	  chain	  in	  the	  inner	  mitochondrion	  membrane	  to	  
produce	  energy	  in	  the	  form	  of	  ATP.	  This	  process,	  oxidative	  phosphorylation,	  is	  achieved	  
by	  the	  movement	  of	  electrons	  along	  four	  complexes	  in	  the	  electron	  transport	  chain.	  
Complex	  I,	  ubiquinone	  oxidoreductase,	  accepts	  two	  electrons	  from	  NADH,	  converting	  
NADH	  to	  NAD+	  and	  at	  the	  same	  time,	  pumps	  hydrogen	  ions	  from	  the	  matrix	  into	  the	  
inner	  membrane	  space.	  Complex	  II,	  succinate	  dehydrogenase	  and	  the	  only	  enzyme	  of	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the	  citric	  acid	  cycle	  not	  found	  in	  the	  matrix	  but	  in	  the	  mitochondrial	  membrane,	  accepts	  
electrons	  from	  FADH2	  in	  order	  to	  reduce	  cytochrome	  c,	  or	  complex	  III,	  and	  more	  
hydrogen	  ions	  are	  pumped	  from	  the	  matrix	  into	  the	  inner	  mitochondrion	  space.	  
Complex	  IV,	  cytochrome	  oxidase,	  passes	  the	  electrons	  along	  the	  chain	  to	  the	  final	  
electron	  acceptor,	  oxygen,	  and	  more	  hydrogen	  ions	  are	  pumped.	  The	  generation	  of	  this	  
electrochemical	  gradient	  across	  the	  membrane	  due	  to	  the	  hydrogen	  ions	  is	  used	  to	  
power	  complex	  V,	  ATP	  synthase	  to	  produce	  ATP	  from	  ADP[105].	  	  
	  
	   The	  interdependence	  of	  proteins	  embedded	  in	  the	  membranes	  coupled	  to	  the	  
chemical	  processes	  results	  in	  a	  dynamic	  and	  fluid	  environment,	  which	  is	  crucial	  for	  
mitochondrial	  function.	  The	  membrane	  impermeability	  of	  the	  inner	  membrane	  to	  
protons	  establishes	  the	  proton	  gradient,	  which	  is	  crucial	  to	  the	  function	  of	  ATP	  
synthase[106].	  The	  fluidity	  of	  the	  membrane	  is	  important	  to	  organizing	  the	  ETC	  
complexes	  and	  when	  the	  optimal	  membrane	  fluidity	  changes,	  mitochondrial	  functions	  
can	  be	  affected[107,	  108],	  as	  membrane	  associated	  enzymes	  function	  less	  
efficiently[105,	  109].	  	  
	  
	  
Figure	  2:	  The	  Electron	  Transport	  Chain	  [105]	  
	  
	   16	  
1.3.2 Ischemic	  Reperfusion	  Injury:	  The	  Important	  Role	  of	  Mitochondria	  in	  the	  Kidneys	  
During	  an	  ischemic	  insult	  to	  the	  kidney,	  key	  mitochondria	  functions	  are	  affected.	  
There	  is	  a	  decreased	  delivery	  of	  oxygen,	  the	  final	  oxygen	  acceptor	  in	  the	  electron	  
transport	  chain	  and	  thus	  this	  decreases	  the	  protection	  afforded	  by	  the	  antioxidant	  
system.	  Slight	  insults,	  or	  short	  periods	  of	  ischemia	  may	  increase	  the	  leakage	  of	  electrons	  
from	  the	  blockage	  of	  ETC	  complexes,	  increasing	  the	  electronegativity	  of	  ETC	  complexes,	  
but	  it	  may	  not	  be	  substantial	  enough	  to	  drastically	  alter	  the	  chemiosmotic	  process	  in	  the	  
mitochondria.	  During	  these	  brief	  ischemic	  insults	  to	  the	  mitochondria,	  the	  damaging	  
effects	  of	  increased	  reactive	  oxygen	  species	  can	  be	  reduced	  following	  reperfusion	  and	  
reintroduction	  of	  oxygen	  to	  the	  system.	  A	  longer	  ischemic	  insult	  can	  result	  in	  longer	  
lasting	  and	  more	  profound	  changes,	  such	  as	  increased	  membrane	  permeability[110]	  and	  
decreased	  activity	  of	  the	  complexes,	  resulting	  in	  low	  ATP	  production[111].	  	  
	  
	   During	  an	  ischemic	  insult,	  there	  can	  also	  be	  an	  increase	  in	  resting	  cytosolic	  
calcium	  ions,	  which	  results	  in	  increased	  concentration	  of	  calcium	  ions	  in	  the	  
mitochondria.	  ATP	  is	  also	  broken	  down	  to	  AMP,	  adenosine	  monophosphate	  and	  
inorganic	  phosphate.	  Due	  to	  the	  inhibition	  of	  the	  inhibition	  of	  Na+/K+	  pump,	  there	  is	  an	  
increase	  in	  the	  level	  of	  cytosolic	  Na+	  ions,	  leading	  to	  a	  rise	  in	  cytosolic	  Ca2+,	  resulting	  in	  
changes	  in	  membrane	  permeability[112-­‐115].	  	  
	  
Increased	  mitochondrial	  inner	  membrane	  permeability	  can	  have	  drastic	  effects	  
on	  the	  cell,	  as	  it	  is	  a	  signal	  for	  apoptosis[116].	  During	  an	  ischemic	  insult,	  there	  can	  be	  the	  
formation	  of	  mitochondrial	  permeability	  transition	  pores	  (MPTP)	  in	  the	  inner	  
mitochondrial	  membrane,	  which	  not	  only	  diminish	  ATP	  production	  through	  proton	  
leakage	  but	  they	  also	  increase	  the	  permeability	  of	  small	  molecules	  and	  water,	  resulting	  
in	  matrix	  swelling	  and	  rupture	  of	  the	  outer	  mitochondrial	  membrane[117].	  Cytochrome	  
c,	  Smac/DIABLO,	  apoptosis	  inducing	  factor	  (AIF)	  are	  released	  into	  the	  cytosol	  by	  the	  
ruptured	  mitochondria,	  resulting	  in	  apoptosis[118].	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1.4.1 Overview	  of	  Gene	  Therapy	  
Gene	  therapy	  allows	  for	  the	  delivery	  of	  exogenous	  genes	  into	  one’s	  cells	  in	  order	  
to	  correct	  a	  genetic	  mutation,	  be	  it	  inherited	  or	  acquired.	  Modifying	  one’s	  genes	  allows	  
for	  altered	  protein	  expression	  patterns,	  and	  it	  is	  a	  promising	  and	  growing	  field	  of	  
medicine	  that	  may	  hold	  a	  cure	  for	  many	  diseases.	  The	  Human	  Genome	  Project	  has	  
provided	  a	  viable	  map	  for	  efforts	  to	  identify	  genes	  and	  potentially	  develop	  gene	  therapy	  
as	  a	  viable	  treatment	  option.	  	  
	  
	  
1.4.2 Recent	  Developments	  in	  Gene	  Therapy	  
For	  diseases	  with	  a	  clear	  target	  for	  therapy,	  for	  example	  CFTR	  gene	  in	  cystic	  
fibrosis,	  gene	  therapy	  presents	  a	  promising	  future.	  There	  is	  the	  vision	  that	  one	  day	  the	  
disease	  can	  be	  eliminated	  or	  prevented	  when	  the	  gene	  is	  delivered	  to	  the	  correct	  target	  
and	  the	  problem	  fixed	  efficiently	  while	  avoiding	  the	  side	  effects	  of	  drugs.	  Gene	  
therapies	  cannot	  only	  treat	  genetic	  diseases,	  but	  also	  cancer,	  viral	  infections	  and	  
neurodegenerative	  diseases.	  Many	  clinical	  trials	  are	  focused	  on	  cancer	  treatment,	  
mostly	  in	  phase	  I	  or	  II	  and	  focused	  primarily	  on	  the	  safety	  of	  genetic	  treatment[119].	  
Recently,	  gene	  therapy	  has	  improved	  muscle	  strength	  in	  a	  dog	  model	  of	  a	  fatal	  
congenital	  childhood	  disease	  caused	  by	  the	  MIM1	  gene	  mutation[120].	  	  
	  	  
There	  are	  two	  critical	  factors	  to	  be	  considered	  in	  a	  viable	  gene	  therapy	  
treatment:	  efficiency	  and	  sustained	  expression.	  In	  the	  first	  of	  its	  kind,	  in	  1990,	  a	  
retroviral	  vector	  adenosine	  deaminase	  (ADA)	  gene	  was	  transferred	  into	  the	  T	  cells	  of	  
two	  children	  with	  severe	  combined	  immunodeficiency	  (ADA-­‐SCID).	  The	  genes	  were	  able	  
to	  normalize	  circulating	  T	  cells,	  as	  well	  as	  other	  cellular	  and	  humoral	  immune	  responses.	  
However,	  after	  two	  years	  of	  gene	  treatment,	  the	  effects	  only	  lasted	  4	  years[121].	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There	  is	  also	  the	  question	  of	  a	  delivery	  vehicle	  or	  the	  vector.	  There	  are	  two	  
categories:	  viral	  and	  non-­‐viral.	  Non-­‐viral	  vectors	  involve	  injecting	  DNA	  directly,	  mixing	  
with	  polylysine	  or	  cationic	  lipids	  in	  order	  to	  cross	  the	  cell	  membrane,	  etc.	  The	  advantage	  
of	  non-­‐viral	  delivery	  is	  that	  it	  is	  safer	  than	  viral	  vectors	  but	  there	  is	  poor	  efficiency	  of	  
delivery	  as	  well	  as	  transient	  expression	  of	  the	  gene,	  rendering	  it	  relatively	  ineffective	  as	  
a	  treatment	  option[122].	  	  
	  
Viral	  vectors	  utilize	  specialized	  molecular	  mechanism	  refined	  by	  evolution	  to	  
deliver	  DNA	  to	  cells,	  allowing	  for	  persistent	  expression	  of	  the	  transgene.	  On	  the	  other	  
hand,	  there	  are	  the	  concerns	  of	  toxicity,	  immune	  and	  inflammatory	  response,	  gene	  
control,	  targeting	  to	  the	  correct	  tissues,	  the	  risk	  of	  the	  vector	  to	  recover	  its	  ability	  to	  








1.4.3.1 Exogenous	  Transgene	  Vectors	  
The	  delivery	  of	  a	  safe	  and	  effective	  vector	  is	  critical	  to	  the	  success	  of	  genetic	  
therapy.	  It	  is	  important	  to	  develop	  capable	  technologies	  that	  allow	  the	  vectors	  to	  target	  
specific	  cells	  and	  achieve	  sustained	  gene	  expression	  while	  minimizing	  adverse	  effects.	  	  
	  
There	  are	  five	  classes	  of	  viral	  vectors	  divided	  into	  two	  groups,	  integrating	  vectors	  
and	  nonintegrating	  vectors.	  Retroviruses	  and	  lentiviruses	  are	  integrating	  vectors	  that	  
allows	  for	  genome	  integration	  into	  host	  DNA,	  transducing	  dividing	  cells.	  However,	  
genomes	  of	  integrating	  vectors	  can	  be	  silenced	  over	  time	  and	  thus,	  using	  these	  vectors	  
does	  not	  solve	  the	  problem	  of	  transient	  expression.	  Adenoviruses,	  adeno-­‐associated	  
viruses	  and	  herpes	  simplex-­‐1	  viruses	  are	  non-­‐integrating	  viruses,	  whose	  genomes	  are	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not	  integrated	  into	  the	  host	  genome	  but	  instead	  exists	  as	  extrachromosomal	  episomes	  
and	  mediate	  sustained	  transgene	  expression	  in	  non-­‐dividing	  cells[124].	  	  
	  
With	  viral	  vectors,	  there	  are	  the	  issues	  of	  insertional	  mutagenesis,	  gene	  control,	  
targeting	  and	  pathogenic	  side	  effects.	  	  Non-­‐viral	  vectors,	  compared	  to	  viral	  methods	  are	  





1.4.3.2 Efficient	  Renal	  Gene	  Delivery	  Techniques	  
However,	  non-­‐viral	  vectors	  cannot	  pass	  through	  cellular	  barriers	  to	  access	  host	  
DNA[126]	  and	  in	  order	  to	  be	  a	  viable	  treatment	  method,	  there	  needs	  to	  be	  a	  delivery	  
method	  that	  facilitates	  the	  passage	  of	  non-­‐viral	  vectors	  across	  the	  cell	  membrane,	  
through	  the	  nuclear	  membrane	  and	  onto	  host	  chromatin.	  Non-­‐viral	  vectors	  involve	  
injecting	  DNA	  directly,	  mixing	  with	  polylysine	  or	  cationic	  lipids	  in	  order	  to	  cross	  the	  cell	  
membrane.	  In	  an	  instance	  of	  direct	  injection,	  naked	  DNA	  was	  injected	  in	  in	  vivo	  murine	  
with	  localized,	  long	  lasting	  protein	  expression	  effects[127].	  	  	  
	  
Another	  option	  is	  packaging	  plasmid	  DNA	  with	  liposomes	  in	  order	  to	  facilitate	  
the	  delivery	  of	  the	  DNA	  across	  membranes	  and	  the	  package	  is	  administered	  via	  
intravenous	  injection.	  There	  is	  risk	  of	  toxicity	  and	  immunogenicity.	  In	  addition	  to	  
liposomes,	  packing	  with	  cationic	  lipids,	  can	  deliver	  the	  DNA	  efficiently	  across	  the	  cell	  
membrane	  as	  well.	  Cationic	  lipids	  interacts	  high	  affinity	  with	  cell	  membranes	  and	  once	  it	  
crosses	  the	  membrane,	  the	  cationic	  lipids	  are	  dispersed	  in	  the	  cytoplasm,	  allowing	  the	  
plasmid	  to	  be	  released	  from	  endosomal	  compartments	  but	  the	  efficiency	  of	  DNA	  
transfer	  into	  the	  nucleus	  has	  yet	  to	  be	  determined[128].	  Another	  method	  in	  use	  is	  the	  
use	  of	  biocompatible,	  biodegradable	  polymer	  as	  a	  plasmid	  carrier,	  similar	  to	  the	  
mechanism	  of	  liposomes	  and	  cationic	  lipids.	  These	  methods	  have	  been	  studied	  in	  efforts	  
to	  treat	  cystic	  fibrosis	  and	  cancer	  but	  transfection	  efficiency	  is	  still	  an	  issue[129].	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There	  are	  challenges	  that	  need	  to	  be	  overcome	  in	  order	  for	  efficient	  and	  
persistent	  gene	  transfer	  and	  expression	  in	  the	  kidney,	  due	  to	  its	  unique	  and	  complex	  
anatomy.	  The	  glomerular	  filtration	  barrier	  blocks	  the	  transgene’s	  accessibility	  to	  the	  
apical	  domain	  of	  epithelial	  cells,	  and	  that	  limits	  the	  uptake	  of	  the	  transgene[130-­‐132].	  
Proximal	  tubule	  epithelial	  cells	  can	  work	  as	  potential	  transgene	  target	  due	  to	  their	  
capacity	  to	  endocytose	  exogenous	  materials.	  In	  adenovirus	  delivery	  via	  different	  
methods,	  the	  levels	  of	  gene	  expression	  differed	  across	  renal	  cell	  types	  and	  regions	  of	  
the	  kidney,	  possibly	  due	  to	  the	  differences	  in	  transgene	  infusion	  site,	  volume	  and	  rate	  of	  
delivery,	  organ	  temperature	  and	  use	  of	  vasodilators.	  The	  types	  of	  deliveries	  include	  
arterial	  injections	  in	  normal	  and	  cystic	  rats	  [133],	  pelvic	  catheter	  infusions	  	  [134]	  in	  
normal	  rats	  and	  tail	  vein	  [135]	  and	  cortical	  micropuncture	  injections	  in	  uninjured	  
animals[136].	  	  
	  
One	  method	  of	  delivery	  that	  holds	  promise,	  addressing	  the	  issue	  of	  efficient	  
delivery	  to	  the	  unique	  structures	  of	  the	  kidney,	  is	  hydrodynamic	  fluid	  delivery,	  as	  it	  




1.4.3.3 The	  Construction	  of	  Non-­‐Viral	  Vectors	  
There	  is	  still	  the	  issue	  of	  the	  vehicle	  for	  the	  gene	  of	  interest	  and	  plasmids,	  circular	  
double	  stranded	  DNA	  molecules,	  hold	  promise.	  These	  extrachromosomal	  DNAs	  occur	  
naturally	  in	  bacteria	  and	  yeast.	  There	  are	  three	  important	  elements	  to	  a	  plasmid	  vector:	  
1)	  an	  origin	  of	  replication	  to	  allow	  for	  replication	  in	  the	  bacterial	  cells	  (for	  amplification	  
and	  subsequent	  purification),	  2)	  a	  selectable	  marker,	  usually	  a	  drug-­‐resistance	  gene,	  3)	  
and	  a	  region	  for	  DNA	  of	  interest	  insertion.	  Expression	  vectors	  also	  require	  specific	  
sequences	  that	  allows	  for	  protection,	  insertion	  and	  expression:	  	  
1) a	  polyadenylation	  tail	  in	  order	  to	  protect	  mRNAs	  from	  exonucleases	  and	  
ensure	  translational	  termination	  and	  stabilize	  mRNA	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2) Kozak	  sequence	  for	  ribosome	  assembly	  
3) Promotor	  for	  initiating	  transcription	  for	  the	  vector’s	  transgene	  
4) reporter	  genes	  for	  identifying	  that	  the	  plasmid	  contains	  inserted	  DNA	  
sequence	  
5) Targeting	  sequence	  for	  targeting	  the	  expressed	  protein	  to	  specific	  locations	  
6) Protein	  purification	  tags	  for	  purifying	  the	  expressed	  protein.	  	  
	  
One	  issue	  is	  that	  if	  the	  plasmid	  containing	  the	  drug	  resistant	  gene	  is	  delivered	  and	  








1.5.1 Hydrodynamic	  Fluid	  Delivery	  
In	  the	  late	  1990s,	  hydrodynamic	  fluid	  delivery	  was	  developed	  to	  deliver	  plasmid	  
DNA	  to	  whole	  animals	  through	  intravascular	  injection.	  The	  unique	  characteristic	  of	  fluid	  
pressure	  generated	  in	  vessels	  allowed	  for	  enhanced	  endothelial	  and	  parenchymal	  cell	  
permeability[138-­‐140].	  This	  new	  delivery	  approach	  for	  non-­‐viral	  genes	  seemed	  efficient,	  
safe	  and	  convenient,	  minimizing	  the	  downsides	  of	  other	  delivery	  methods	  and	  viral	  
genes.	  There	  have	  been	  instances	  shown	  when	  hydrodynamic	  delivery	  enabled	  
sustained	  transgene	  expression	  in	  transfected	  animals,	  reaching	  therapeutic	  levels[141-­‐
148].	  Early	  studies	  involving	  other	  organs	  like	  the	  liver	  established	  this	  method	  as	  a	  
potentially	  effective	  method	  for	  delivery	  and	  thus	  this	  procedure	  can	  be	  adapted	  and	  
extrapolated	  for	  use	  in	  other	  organs[149-­‐153].	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1.5.2 Mechanism	  of	  Hydrodynamic	  Fluid	  Delivery	  
The	  purpose	  of	  hydrodynamic	  fluid	  delivery	  is	  to	  increase	  fluid	  flow	  from	  
pressurized	  injections,	  generating	  transient	  pores	  in	  the	  capillary	  endothelium	  and	  
epithelium[154].	  Theoretically,	  the	  increased	  fluid	  flow	  and	  disruption	  of	  physical	  
barriers	  allows	  delivery	  of	  target	  DNA	  to	  access	  the	  plasma	  membranes	  of	  the	  
surrounding	  parenchyma	  cells.	  Then,	  when	  the	  pressure	  is	  removed,	  these	  exogenous	  
materials	  are	  trapped	  inside	  the	  parenchyma	  cells,	  as	  the	  physical	  barriers	  are	  reformed	  
by	  the	  capillary	  endothelium[155-­‐157].	  	  
	  
	  
1.5.3 Characterizations	  of	  Various	  Hydrodynamic	  Gene	  Delivery	  Techniques	  
In	  previous	  work	  done	  by	  Dr.	  Corridon	  in	  the	  Atkinson	  lab,	  hydrodynamic	  fluid	  
delivery	  was	  attempted	  in	  several	  ways	  in	  order	  to	  optimize	  a	  delivery	  technique	  that	  
maximizes	  efficiency	  of	  the	  expression	  of	  the	  transgene	  while	  minimizing	  damage	  to	  the	  
kidney	  tissue.	  Large	  molecular	  weight	  dye	  150kDa	  FITC	  was	  used	  as	  a	  molecular	  probe	  
to	  visualize	  a	  renal	  capsule	  injection	  into	  rat	  kidneys.	  A	  significant	  amount	  of	  large	  
molecular	  weight	  dye	  was	  found	  in	  the	  vasculature	  but	  the	  distribution	  was	  uneven	  and	  
confined	  to	  the	  injection	  site.	  Catheter-­‐based	  renal	  artery	  injections	  were	  then	  
attempted,	  where	  a	  live	  rat	  received	  a	  hydrodynamic	  injection	  of	  the	  large	  molecular	  
weight	  molecule,	  infused	  through	  a	  ligated	  renal	  artery	  via	  a	  PE-­‐50	  catheter.	  There	  was	  
widespread	  distribution	  of	  the	  dextran	  molecules,	  within	  the	  lumens	  of	  proximal	  and	  
distal	  tubules	  as	  well	  as	  internalized	  within	  the	  proximal	  tubule	  epithelial	  cells.	  However,	  
there	  were	  signs	  of	  significant	  renal	  injury	  in	  the	  form	  of	  constructed	  vessels,	  occluded	  
lumens	  and	  a	  large	  concentration	  of	  blebs	  within	  the	  lumens.	  	  
	  
Since	  the	  renal	  artery	  hydrodynamic	  catheter-­‐based	  injections	  resulted	  in	  
successful	  and	  widespread	  distribution	  of	  molecular	  probes	  but	  resulted	  in	  significant	  
renal	  injury,	  catheter-­‐based	  renal	  vein	  injections	  were	  attempted	  with	  Texas	  red-­‐labeled	  
albumin	  on	  live	  rat	  kidney.	  There	  was	  significant	  renal	  injury	  observed	  as	  well.	  Then,	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hydrodynamic	  fine	  needle	  renal	  arterial	  injections	  were	  attempted	  with	  low	  molecular	  
weight	  (5kDa	  FITC	  dextran)	  exogenous	  probes,	  resulting	  in	  an	  uneven	  distribution	  of	  
dextran	  molecules,	  which	  were	  found	  endocytosed	  by	  proximal	  tubule	  epithelial	  cells	  in	  
low	  amounts.	  Significant	  injury	  was	  observed	  as	  well,	  as	  there	  was	  patchy	  distribution	  of	  
dextran,	  fluorescent	  debris	  and	  non-­‐fluorescent	  blebs	  within	  proximal	  and	  distal	  tubule	  
lumens.	  When	  the	  hydrodynamic	  arterial	  injection	  with	  single	  aorta	  and	  renal	  vein	  
clamp	  was	  repeated	  with	  large	  molecular	  probes	  (150kDa	  FITC	  dextran),	  followed	  by	  a	  
subsequent	  long	  period	  of	  jugular	  vein	  infusion	  of	  150kDa	  TRITC	  dextran,	  there	  was	  
significant	  amount	  of	  blood	  loss	  to	  the	  injection	  site.	  The	  probes	  were	  unevenly	  
distributed	  within	  the	  glomerular	  and	  peritubular	  capillaries,	  with	  a	  more	  uniform	  
fluorescent	  signal	  within	  the	  proximal	  tubule	  epithelial	  cells.	  	  
	  
The	  focus	  was	  then	  shifted	  to	  hydrodynamic	  fine	  needle	  renal	  venous	  injections	  
with	  small	  (3kDa	  Cascade	  Blue	  or	  4kDa	  FITC)	  and	  large	  dextrans	  (150kDa	  TRITC).	  Using	  a	  
30-­‐gauge	  needle,	  these	  molecular	  probes	  were	  injected	  at	  different	  infusion	  rats	  ranging	  
from	  10	  seconds	  to	  4	  minutes	  with	  and	  without	  vascular	  clamping.	  Widespread	  uptake	  
of	  both	  dextrans	  were	  observed	  in	  vivo,	  with	  low	  molecular	  dextran	  molecules	  bound	  to	  
brush	  border	  membranes	  of	  the	  proximal	  tubular	  epithelia.	  Internalization	  of	  the	  low	  
molecular	  weight	  probes	  were	  observed	  in	  the	  epithelial	  cells	  and	  concentrated	  levels	  of	  
the	  dextrans	  appeared	  within	  distal	  tubule	  lumens.	  Large	  molecular	  weight	  dextran	  
were	  widely	  distributed	  within	  the	  vasculature,	  internalized	  by	  tubular	  cells	  and	  
unexpectedly	  filtered	  through	  tubules.	  Proximal	  tubule	  epithelial	  cells	  have	  
incorporated	  low	  and	  high	  molecular	  weight	  dextrans	  along	  basolateral	  and	  apical	  
membranes.	  After	  the	  renal	  vein	  hydrodynamic	  injection,	  normal	  renal	  tissue	  integrity	  is	  
restored,	  as	  shown	  by	  restriction	  of	  large	  TRITC	  dextran	  molecules	  to	  vascular	  
compartments	  during	  a	  jugular	  infusion	  of	  150kDa	  TRITC	  molecules.	  	  
	  
When	  plasmid	  eGFP	  DNA	  were	  hydrodynamically	  injected	  through	  the	  renal	  vein	  
into	  rat	  kidneys	  without	  vascular	  clamps,	  there	  were	  limited	  levels	  of	  transgene	  
	   24	  
expression	  within	  the	  superficial	  cortex	  as	  well	  as	  the	  renal	  medulla.	  When	  the	  
hydrodynamic	  injections	  were	  repeated	  with	  vascular	  clamps	  (Figure	  6),	  there	  was	  
robust	  expression	  of	  GFP	  and	  GFP-­‐tubulin	  in	  live	  rat	  kidneys.	  Transgene	  expression	  was	  
visualized	  in	  distal	  and	  proximal	  tubule	  epithelial	  cells.	  The	  GFP	  fluorescence	  intensified	  
along	  the	  brush	  border	  of	  cells.	  Hydrodynamic	  delivery	  also	  facilitates	  the	  expression	  of	  
a	  variety	  of	  plasmid	  vectors	  in	  live	  rat	  kidneys	  including	  EGFP-­‐occludin,	  H2B-­‐tdTomato	  
and	  EGFP	  actin[137].	  
	  
Hydrodynamic	  renal	  vein	  injections	  were	  also	  attempted	  using	  baculovirus	  and	  
adenoviruses	  in	  addition	  to	  plasmids.	  When	  the	  percentage	  of	  nephron	  cross-­‐sections	  
that	  were	  expressing	  the	  transgene	  was	  measured,	  expression	  of	  the	  transgene	  was	  the	  
highest	  in	  the	  superficial	  renal	  cortex	  	  (78%	  to	  86%)	  and	  cortico-­‐medullary	  junction.	  The	  
high	  level	  of	  eGFP	  fluorescent	  protein	  persisted	  in	  the	  superficial	  region	  of	  the	  cortex	  for	  
up	  to	  4	  weeks	  (28-­‐68%).	  Serum	  creatinine	  in	  rats	  remained	  within	  normal	  baseline	  levels	  
(0.3-­‐0.5mg/dl)	  throughout	  the	  measurement	  period	  of	  up	  to	  14	  days	  after	  the	  
hydrodynamic	  fluid	  delivery,	  with	  no	  significant	  difference	  between	  rats	  that	  received	  
saline	  and	  rats	  that	  received	  vectors.	  Thus,	  transgene	  expression	  appears	  to	  be	  
relatively	  long	  lived	  and	  minimized	  injury	  using	  a	  hydrodynamic	  fluid	  retrograde	  renal	  














	   25	  




1.6.1 IDH2:	  An	  Important	  Mitochondria	  Protein	  
Isocitrate	  dehydrogenase	  2	  is	  a	  member	  of	  isocitrate	  dehydrogenases	  (IDHs),	  a	  
group	  of	  proteins	  with	  crucial	  functions	  and	  catalyzes	  the	  oxidative	  decarboxylation	  of	  
isocitrate	  to	  alpha-­‐ketoglutarate[158].	  There	  are	  three	  IDH	  genes,	  IDH1,	  IDH2	  and	  IDH3.	  
IDH1	  and	  IDH2	  are	  NADPH-­‐dependent	  enzymes	  and	  share	  similar	  structure[159].	  IDH3	  is	  
a	  NAD+-­‐dependent	  enzyme	  located	  in	  the	  mitochondrial	  matrix	  and	  participates	  in	  the	  
Krebs	  cycle.	  IDH1	  and	  IDH2	  catalyze	  reversible	  reactions	  of	  decarboxylating	  isocitrate	  to	  
2-­‐oxoglutarate	  while	  reducing	  NADP+	  to	  NADPH,	  while	  IDH3	  irreversibly	  decarboxylates	  
isocitrate	  to	  2-­‐oxoglutarate	  while	  reducing	  NAD+	  to	  NADH[160].	  	  
	  
IDH1	  is	  localized	  to	  the	  cytoplasm	  and	  peroxisomes.	  It	  is	  highly	  expressed	  in	  the	  
liver	  and	  besides	  having	  the	  ability	  to	  catalyze	  the	  conversion	  of	  isocitrate	  to	  alpha-­‐
ketoglutarate,	  IDH1	  is	  also	  shown	  to	  be	  involved	  in	  lipid	  and	  glucose	  metabolism[161,	  
162]	  as	  well	  as	  the	  cellular	  defense	  against	  ROS	  and	  radiation	  [163-­‐165].	  IDH2	  is	  found	  in	  
the	  mitochondrial	  matrix	  and	  highly	  expressed	  in	  heart,	  muscle	  and	  activated	  
lymphocytes[166].	  IDH2	  regulates	  the	  citric	  acid	  cycle	  and	  protects	  cells	  against	  
oxidative	  stress[167].	  Mutations	  in	  IDH1	  and	  IDH2	  contribute	  to	  tumorigenesis	  and	  
cancer	  progression	  through	  indirect	  effects	  on	  the	  overall	  mutation	  rate	  in	  gliomas	  and	  
acute	  myeloid	  leukemia[168].	  	  
	  
	  
1.6.2 Proteomics	  and	  the	  Roles	  of	  IDH2	  in	  Protecting	  Renal	  Function	  
Ischemic	  preconditioning	  (IP)	  is	  a	  method	  used	  to	  confer	  resistance	  to	  further	  
injury	  caused	  by	  the	  loss	  of	  blood	  supply	  and	  oxygen.	  When	  ischemia	  is	  induced	  in	  a	  rat	  
kidney	  for	  a	  brief	  period	  of	  time	  and	  restored,	  the	  kidney	  is	  protected	  from	  a	  
subsequent	  ischemic	  insult	  for	  an	  extended	  period	  of	  time,	  as	  measured	  by	  serum	  
	   26	  
creatinine	  measurements[89].	  The	  mechanism	  is	  not	  yet	  fully	  understood	  but	  one	  
proposed	  mechanism	  is	  that	  IP	  alters	  the	  expression	  of	  mitochondrial	  proteins	  in	  
response	  to	  the	  preconditioning	  event,	  allowing	  for	  better	  recovery	  in	  subsequent	  
insults.	  Proteomic	  analysis	  carried	  out	  by	  Dr.	  Bacallao,	  Dr.	  Basile	  and	  Dr.	  Witzmann	  
showed	  that	  several	  proteins	  in	  the	  renal	  mitochondria	  were	  elevated	  beyond	  baseline	  
levels	  following	  a	  preconditioning	  event	  (Table	  2).	  The	  two	  most	  elevated	  proteins,	  IDH2	  
and	  SULT1C2,	  were	  selected	  for	  further	  analysis.	  Dr.	  Corridon	  performed	  several	  
experiments	  demonstrating	  that	  the	  hydrodynamic	  delivery	  of	  IDH2	  genes	  can	  protect	  
the	  kidney	  from	  AKI	  generated	  from	  IRI.	  	  
	  
Table	  2:	  Proteomic	  Screen	  listing	  changes	  in	  protein	  expression	  in	  rat	  kidney	  
mitochondria	  fractions	  following	  IRI[137].	  
Gene	  
Symbol	  




SULT1C1	   Sulfotransferase	  1C2-­‐like	   2.4	   0.40	  
IDH2	   Isocitrate	  dehydrogenase	  
(NADP)	  mitochondrial	  
2.2	   0.31	  
HIST1H2BC	   Histone	  H2B	   2.0	   0.25	  
C1QBP	   Complement	  component	  1	  Q	  subcomponent-­‐binding	  
protein	  
1.9	   0.26	  
ACOT2	   Acyl-­‐coenzyme	  A	  thioesterase	  2,	  mitochondrial	   1.5	   0.53	  
ACSL1	   Long-­‐chain-­‐fatty-­‐acid-­‐COA	  ligase	  1	   1.7	   0.29	  
THUMPD2	   THUMP	  domain	  containing	  2	  isoform	  1	   -­‐3.0	   0.09	  
MTCH2	   Mitochondrial	  carrier	  homolog	  2	   -­‐1.9	   0.27	  
HSDL2	   Hydroxysteroid	  dehydrogenase-­‐like	  protein	  2	   -­‐1.6	   0.37	  
SLC25A13	   Solute	  carrier	  family	  25,	  member	  13	   -­‐1.6	   0.13	  
NDUFA5	   NADH	  dehydrogenase	  (ubiquinone)	  1	  α	  
subcomplex	  subunit	  5	  
-­‐1.6	   0.33	  
SUCLG1	   Succinate-­‐COA	  ligase,	  alpha	  subunit	   -­‐1.6	   0.04	  
ISCA2	   Iron-­‐sulfur	  cluster	  assembly	  2	  homolog	   -­‐1.3	   0.01	  
	  
	  
In	  these	  experiments	  by	  Dr.	  Corridon,	  serum	  creatinine	  measurements	  were	  
used	  a	  standard	  biomarker	  for	  evaluating	  renal	  function.	  Creatinine	  is	  a	  byproduct	  of	  
normal	  muscle	  metabolism	  and	  is	  excreted	  by	  the	  kidney	  at	  a	  relatively	  constant	  rate.	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When	  kidney	  function	  is	  impaired,	  nephron	  capacity	  to	  clear	  serum	  creatinine	  is	  limited.	  
Less	  serum	  creatinine	  is	  excreted[29],	  thereby	  increasing	  serum	  creatinine	  levels.	  	  
	  
Dr.	  Corridon	  first	  performed	  hydrodynamic	  retrograde	  renal	  injections	  of	  either	  
saline	  or	  IDH2	  plasmid	  into	  Sprague-­‐Dawley	  rat	  kidneys,	  and	  at	  day	  7,	  they	  were	  
subjected	  to	  a	  moderate	  ischemia-­‐reperfusion	  injury	  (IRI).	  Serum	  creatinine	  (sCR)	  
measurements	  were	  taken	  for	  a	  week	  after	  enduring	  IRI.	  The	  sCR	  measurements	  
showed	  that	  the	  hydrodynamic	  delivery	  of	  IDH2	  or	  SULT1C2	  genes	  was	  sufficient	  to	  
ameliorate	  the	  effect	  of	  an	  IRI	  in	  these	  rats,	  mirroring	  a	  similar	  response	  when	  the	  
treatment	  at	  day	  one	  was	  a	  preconditioning	  event.	  sCR	  levels	  remained	  within	  normal	  
levels	  despite	  the	  moderate	  injury	  as	  compared	  to	  rats	  that	  received	  hydrodynamic	  or	  
tail	  injects	  of	  saline	  or	  fluorescent	  proteins.	  	  
	  
Since	  IDH2	  and	  SULT1C2	  are	  postulated	  to	  have	  an	  effect	  in	  mitochondria,	  Dr.	  
Corridon	  evaluated	  mitochondrial	  activity	  in	  vivo	  using	  two-­‐photon	  microscopy	  and	  
mitochondria	  potential	  sensitive	  dye	  tetramethyl	  rhodamine	  methyl	  ester	  (TMRM).	  
TMRM	  is	  a	  fluorescent	  probe	  which	  binds	  to	  the	  inner	  and	  outer	  layers	  of	  the	  inner	  
mitochondrial	  membrane	  and	  as	  an	  assay,	  allows	  us	  to	  monitor	  the	  membrane	  potential	  
changes	  in	  the	  mitochondria.	  	  
	  
In	  Sprague	  Dawley	  rats,	  jugular	  vein	  infusions	  of	  the	  TMRM	  dye	  was	  used	  to	  gain	  
insight	  into	  mitochondria	  function.	  In	  normal	  rats,	  there	  was	  instantaneous	  and	  non-­‐
uniform	  basolateral	  TMRM	  uptake	  in	  the	  proximal	  and	  distal	  tubule	  epithelia	  cells.	  After	  
subjecting	  the	  rats	  to	  30-­‐45	  minutes	  of	  unilateral	  ischemia	  (corresponding	  to	  a	  
moderate	  injury)	  via	  a	  ligature	  placed	  around	  the	  left	  renal	  pedicle	  of	  the	  kidney	  that	  
received	  the	  hydrodynamic	  injection,	  there	  were	  abrupt	  decreases	  in	  TMRM	  fluorescent	  
signals.	  The	  TMRM	  signals	  were	  eventually	  reduced	  to	  autofluorescent	  levels	  about	  30	  
minutes	  after	  ischemia	  and	  this	  illustrates	  the	  rapid	  depolarization	  of	  mitochondria	  
generated	  by	  ischemia.	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However,	  during	  the	  restoration	  of	  blood	  flow,	  there	  was	  a	  gradual	  increase	  in	  
the	  TMRM	  signal,	  showing	  mitochondrial	  repolarization	  in	  vivo.	  The	  TMRM	  signal	  
returned	  to	  its	  initial	  elevated	  levels	  about	  15	  minutes	  after	  reperfusion.	  The	  increase	  in	  
TMRM	  fluorescence	  showed	  the	  regeneration	  of	  mitochondrial	  potential	  but	  it	  was	  not	  
uniformly	  observed	  throughout	  the	  kidney	  after	  reperfusion,	  showing	  that	  moderate	  IRI	  
was	  significant	  enough	  to	  impair	  some	  mitochondrial	  repolarization	  function.	  This	  
results	  compare	  to	  previous	  reported	  results[169].	  
	  
In	  comparison	  to	  rats	  which	  have	  previous	  received	  a	  hydrodynamic	  retrograde	  
renal	  injection	  of	  either	  IDH2	  or	  SULT1C2	  plasmid	  vectors,	  as	  those	  that	  have	  received	  
IP,	  the	  TMRM	  fluorescent	  signal	  intensities	  were	  significantly	  greater	  than	  those	  
measure	  in	  sham	  and	  vehicle	  rats	  (injected	  with	  saline).	  This	  shows	  that	  there	  is	  
potential	  increase	  in	  mitochondrial	  activity	  related	  to	  the	  upregulation	  of	  the	  
mitochondrial	  enzymes	  facilitated	  by	  the	  hydrodynamically	  injected	  IDH2	  and	  SULT1C2	  
genes	  as	  well	  as	  IP.	  The	  upregulation	  in	  protein	  expression	  of	  IDH2	  and	  SULT1C	  was	  
confirmed	  using	  Western	  analysis	  and	  supports	  the	  previously	  described	  TMRM	  data.	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Figure	  3:	  Mitochondria	  Membrane	  Potential	  activity	  examined	  in	  nephron	  segments	  of	  
live	  rats	  visualized	  with	  TMRM	  dye	  [137]	  
	  (A)	  –	  baseline	  autofluorescence	  in	  a	  normal	  rat	  that	  has	  not	  received	  the	  TMRM	  dye.	  (B)	  
Saline	  injected.	  (C)	  IDH2	  plasmid	  injected.	  (D)SULT1C2	  plasmid	  injected.	  (E)	  SULT1C2	  
plasmid	  injected	  in	  unilaterally	  nephrectomized	  (right	  kidney	  removed)	  rats.	  (F)	  was	  
subjected	  to	  ischemic	  preconditioning	  and	  did	  not	  receive	  any	  injections.	  TMRM	  were	  
introduced	  via	  the	  jugular	  vein	  after	  the	  kidneys	  were	  subjected	  to	  30mins	  of	  ischemia,	  
7	  days	  after	  receiving	  hydrodynamic	  fluid	  delivery	  or	  IRI	  treatment.	  The	  kidneys	  were	  
imaged	  about	  15-­‐20minutes	  after	  the	  jugular	  vein	  infusion	  of	  TMRM	  and	  renal	  blood	  
flow	  restored	  (taken	  from	  Dr.	  Peter	  Corridon’s	  thesis[137]).	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Figure	  4:	  Time	  Progression	  of	  Serum	  Creatinine	  (sCR)	  values	  in	  hydrodynamically	  
injected	  rats.[137]	  
At	  day	  0,	  rats	  are	  hydrodynamically	  injected	  with	  various	  plasmid	  solutions	  or	  saline	  as	  
denoted	  by	  the	  legend.	  At	  day	  7,	  rats	  are	  injured	  via	  moderate	  IRI	  and	  sCR	  values	  are	  
taken	  every	  day	  post	  injury	  up	  to	  seven	  days.	  Rats	  injected	  with	  IDH2	  and	  SULT1C2	  
enzymes	  have	  lower	  sCR	  values	  one	  day	  post-­‐IRI,	  thus	  showing	  that	  the	  enzymes	  protect	  
the	  kidney	  from	  moderate	  forms	  of	  AKI.	  	  (Taken	  from	  Dr.	  Peter	  Corridon’s	  thesis[137])	  
	  
	  
1.7 In	  Vitro	  Assays	  for	  Mitochondrial	  Respiration	  
In	  1955,	  Chance	  and	  Williams	  defined	  respiratory	  control	  states	  and	  designed	  a	  
protocol	  for	  mitochondrial	  activity	  measure	  with	  isolated	  mitochondria.	  The	  in	  vitro	  
measurement	  of	  mitochondrial	  oxygen	  consumption	  uses	  various	  manipulations	  in	  
order	  to	  monitor	  several	  different	  functional	  states	  (figure	  5).	  The	  first	  state	  is	  state	  1,	  
where	  mitochondria	  are	  added	  to	  an	  isosmotic	  medium	  containing	  phosphate.	  
Respiration	  is	  slow	  due	  to	  a	  lack	  of	  substrate	  in	  the	  medium.	  Substrates	  like	  succinate,	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pyruvate,	  isocitrate,	  alpha-­‐ketoglutarate	  and	  malate	  are	  then	  added	  for	  state	  2.	  
Mitochondrial	  oxygen	  respiration	  in	  state	  2	  is	  still	  low	  in	  the	  presence	  of	  substrate	  due	  
to	  the	  lack	  of	  ADP,	  as	  state	  2	  represents	  the	  oxygen	  consumption	  before	  the	  addition	  of	  
ADP.	  In	  state	  3,	  oxygen	  consumption	  is	  stimulated	  by	  the	  addition	  of	  ADP	  and	  
respiration	  is	  activated	  with	  the	  presence	  of	  both	  the	  substrate	  and	  ADP.	  Respiration	  is	  
ramped	  up	  and	  oxygen	  consumption	  can	  be	  represented	  as	  a	  function	  of	  slope.	  ADP	  is	  
used	  up	  by	  the	  phosphorylation	  of	  ADP	  to	  ATP	  by	  the	  mitochondria.	  Respiration	  slowly	  
decreases	  at	  the	  end	  of	  state	  3	  due	  to	  the	  limiting	  factor	  of	  ADP.	  In	  state,	  4,	  ADP	  is	  a	  
limiting	  factor	  and	  respiration	  declines.	  In	  state	  5,	  there	  is	  a	  lack	  of	  oxygen	  in	  the	  closed	  
oxygen	  monitor	  chamber	  and	  that	  restricts	  respiration[170].	  Mitochondrial	  oxygen	  
respiration	  is	  measured	  as	  a	  consumption	  rate	  of	  oxygen	  during	  state	  3	  with	  the	  
presence	  of	  both	  substrate	  and	  ADP	  [170].	  	  
	  
The	  respiratory	  control	  ratio	  (RCI)	  can	  also	  be	  calculated	  by	  taking	  the	  ratio	  of	  state	  
3	  to	  state	  4.	  The	  RCI	  is	  a	  quantification	  of	  mitochondria	  coupling	  and	  the	  higher	  the	  
ratio,	  the	  tighter	  the	  coupling	  between	  the	  mitochondrial	  respiratory	  chain	  and	  
oxidative	  phosphorylation.	  The	  ADP:O	  ratio	  can	  also	  be	  calculated,	  and	  it	  is	  a	  ratio	  
between	  the	  amount	  of	  ADP	  phosphorylated	  and	  the	  amount	  of	  oxygen	  consumed	  
during	  state	  3[170].	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Figure	  5:	  Schematic	  graph	  of	  oxygen	  consumption	  assay.	  
At	  t=0min,	  0.1ml	  blank	  (terzic	  buffer)	  is	  added	  to	  the	  chamber.	  At	  t=1min,	  a	  substrate	  
(0.1mmol)	  is	  added	  (succinate,	  isocitrate	  or	  pyruvate).	  At	  t=2mins,	  2.5umol	  of	  ADP	  is	  
added.	  State	  3	  is	  the	  active	  respiration	  state,	  when	  mitochondria	  are	  actively	  converting	  
ADP	  to	  ATP.	  State	  4	  occurs	  when	  ADP	  is	  exhausted	  and	  respiration	  slows	  down.	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1.8 Hypothesis	  
Our	  hypothesis	  is	  that	  mitochondria	  in	  preconditioned	  rats,	  or	  rats	  that	  have	  
received	  a	  prior	  ischemic	  injury	  two	  weeks	  before	  ischemic-­‐reperfusion	  injury	  before	  
sacrifice,	  can	  mitigate	  the	  second	  injury	  better	  than	  rats	  that	  have	  not	  received	  the	  
preconditioning	  injury	  event.	  This	  alteration	  in	  mitochondria	  oxygen	  consumption	  is	  also	  
seen	  in	  mitochondria	  from	  kidneys	  injected	  with	  hydrodynamically	  injected	  IDH2	  
plasmids.	  	  
	  
In	  a	  previous	  study	  conducted	  by	  our	  collaborators,	  preconditioned	  rats	  were	  
shown	  to	  be	  resistant	  to	  moderate	  ischemic	  injury	  as	  shown	  by	  lower	  serum	  creatinine	  
values	  as	  compared	  to	  rats	  that	  have	  not	  been	  treated	  with	  a	  preconditioning	  event	  of	  
ischemic	  injury.	  In	  these	  preconditioned	  rats,	  IDH2	  has	  been	  shown	  to	  be	  upregulated	  in	  
the	  kidneys	  of	  rats	  that	  are	  resistant	  to	  moderate	  ischemic	  injuries,	  according	  to	  
western	  blot	  analysis.	  Since	  the	  IDH2	  enzyme	  plays	  a	  critical	  role	  in	  the	  citric	  acid	  cycle,	  
we	  hypothesized	  that	  the	  mitochondria	  could	  be	  the	  key	  factor	  in	  facilitating	  such	  a	  
resistance	  to	  further	  insults,	  and	  thus	  in	  a	  two-­‐pronged	  effort,	  we	  hypothesize	  that	  1)	  
mitochondria	  oxygen	  consumption	  in	  preconditioned	  rat	  renal	  mitochondria	  will	  be	  
equal	  or	  better	  as	  compared	  to	  controls,	  and	  better	  compared	  to	  renal	  mitochondria	  
isolated	  from	  injured	  rat	  kidneys	  2)	  mitochondria	  oxygen	  consumption	  in	  
preconditioned	  rat	  renal	  mitochondria	  will	  perform	  similar	  to	  IDH2	  hydrodynamically	  
injected	  kidneys,	  and	  better	  than	  injured,	  saline	  hydrodynamically	  injected	  kidneys.
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2.1 Plasmid	  Vectors	  
Plasmid	  DNA	  was	  isolated	  using	  the	  Qiagen	  Maxi	  Prep	  systems	  (Qiagen,	  Chatsworth,	  
CA).	  The	  plasmids	  were	  encoded	  with	  enhanced	  green	  fluorescent	  protein	  eGFP-­‐actin	  
(Clontech	  Laboratories,	  Mountain	  View,	  CA),	  non-­‐fluorescently	  labeled	  plasmid	  vectors	  
that	  encode	  mitochondrial	  enzymes	  IDH2	  and	  sulfotransferase	  (OriGene	  Technologies,	  
Inc,	  Rockville,	  MD).	  The	  IDH2	  vector	  was	  an	  ORF	  clone	  of	  Homo	  sapiens	  isocitrate	  
dehydrogenase	  2,	  a	  nuclear	  gene	  encoding	  mitochondrial	  protein	  as	  transfection-­‐ready	  
DNA.	  The	  sulfotransferase	  vector	  was	  an	  ORF	  clone	  of	  Homo	  sapiens	  galactose-­‐3-­‐O-­‐
sulfotransferase	  2	  (GAL3ST2)	  as	  transfection-­‐ready	  DNA.	  For	  these	  hydrodynamic	  
injections,	  for	  hydrodynamic	  injections,	  the	  dose	  was	  1	  µg	  of	  plasmid	  DNA/g	  of	  body	  
weight	  diluted	  to	  a	  total	  volume	  of	  0.5ml	  with	  saline.	  	  
	  
	  
2.2 Mouse	  Kidney	  Cell	  Culture	  
S3	  segment	  of	  the	  proximal	  tubule	  epithelial	  cells	  were	  cultured	  in	  a	  mixture	  of	  
500ml	  of	  essential	  media	  with	  7.5%	  sodium	  bicarbonate,	  7%	  fetal	  bovine	  serum	  and	  1%	  
of	  streptomycin	  (Fisher	  Scientific,	  Pittsburgh,	  PA).	  The	  cells	  were	  grown	  in	  a	  37°C,	  5%	  
CO2-­‐38%	  CO2	  humid	  incubator.	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2.3 Cell	  Culture	  Transfection	  
Immortalized	  cell	  cultures	  were	  grown	  in	  35mm	  glass	  bottom,	  no.1.5	  coverslip	  
dishes,	  with	  standard	  thickness	  of	  0.17	  millimeters	  (corning	  Inc.,	  Corning,	  NY).	  We	  used	  
the	  Effectene	  Transfection	  Reagent	  protocol	  provided	  by	  Qiagen	  (Valencia,	  CA),	  for	  
plasmid-­‐based	  transfections.	  We	  transfected	  cells	  at	  a	  multiplicity	  of	  infection	  (MOI)	  of	  
10:1,	  and	  a	  24-­‐hour	  incubation	  period	  using	  both	  types	  of	  viral	  vectors.	  
	  
	  
2.4 DNA	  Agarose	  Gel	  Electrophoresis	  
The	  E-­‐Gel®	  with	  SYBR	  Safe	  1.2%	  agarose	  gel	  (Invitrogen,	  G521801)	  was	  inserted	  into	  
the	  E-­‐Gel®	  PowerBaseTMv.4.	  Each	  well	  of	  the	  gel	  was	  loaded	  with	  500ng	  plasmid	  DNA.	  
The	  electrophoresis	  time	  was	  set	  as	  30	  min.	  
	  
	  
2.5 Live	  Sprague	  Dawley	  Rats	  
Male	  Sprague	  Dawley	  rats	  (Harlan	  Laboratories,	  Indianapolis,	  IN)	  with	  weights	  
ranging	  from	  250g	  to	  350g	  were	  used	  for	  these	  studies.	  The	  rats	  were	  given	  free	  access	  
to	  standard	  rat	  chow	  and	  water	  throughout	  the	  studies.	  Experiments	  were	  conducted	  in	  
accordance	  with	  National	  Institutes	  of	  Health	  Guidelines	  and	  were	  approved	  by	  the	  
Indiana	  University	  School	  of	  Medicine	  Institutional	  Animal	  Care	  and	  Use	  Committee	  
	  
	  
2.6 Transmission	  Electron	  Microscopy	  
The	  specimens	  were	  fixed	  in	  2%Paraformaldehyde/2%Glutaraldehyde	  in	  0.1M	  
phosphate	  buffer.	  After	  fixation	  the	  specimens	  are	  rinsed	  with	  phosphate	  buffered	  
saline	  (PBS)	  followed	  by	  post	  fixation	  with	  1%	  osmium	  tetroxide	  in	  phosphate	  buffer	  for	  
one	  hour.	  After	  rinsing	  again	  with	  PBS	  the	  tissue	  specimens	  are	  dehydrated	  through	  a	  
series	  of	  graded	  ethyl	  alcohols	  from	  70	  to	  100%.	  	  After	  dehydration	  the	  specimens	  were	  
infiltrated	  with	  2	  changes	  of	  100%	  acetone	  and	  a	  50:50	  mixture	  of	  acetone	  and	  the	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embedding	  resin	  (Embed	  812,	  Electron	  Microscopy	  Sciences,	  Hatfield,	  PA)	  for	  overnight.	  
The	  next	  day	  the	  specimens	  are	  transferred	  to	  fresh	  100%	  embedding	  media	  for	  a	  
minimum	  of	  2	  hours,	  then	  embedded	  in	  a	  fresh	  change	  of	  100%	  embedding	  media.	  
Following	  polymerization	  overnight	  at	  60°C	  the	  blocks	  are	  then	  ready	  to	  section.	  	  Thin	  
sections	  were	  cut	  (70-­‐80nm),	  stained	  with	  uranyl	  acetate	  and	  lead	  citrate,	  then	  viewed	  
on	  a	  Tecnai	  BioTwin	  (FEI,	  Hillsboro,	  OR)	  with	  digital	  images	  taken	  with	  an	  AMT	  
(Advanced	  Microscope	  Techniques,	  Danvers,	  MA)	  CCD	  camera.	  	  
	  
	  




2.7.1 Bilateral	  Clamp	  Model	  
Rats	  were	  anesthetized	  with	  intraperitoneal	  injections	  of	  50mg/kg	  pentobarbital	  
(Hospira,	  Inc.,	  Lake	  Forest,	  IL	  and	  CustomMed	  Apothecary,	  Indianapolis,	  IN)	  or	  ketamine	  
xylazine	  ace	  cocktail.	  They	  were	  then	  placed	  on	  a	  heating	  pad	  to	  maintain	  normal	  
physiological	  temperature.	  Using	  a	  standard	  model	  to	  general	  renal	  ischemia-­‐
reperfusion	  injury,	  bilateral	  renal	  pedicle	  clamps	  (Fine	  Science	  Tools,	  Foster	  City,	  CA)	  
were	  applied	  to	  cut	  off	  blood	  flow	  for	  a	  period	  of	  40	  minutes.	  These	  clamp	  periods	  
correspond	  to	  moderate	  kidney	  injury[154,	  171].	  After	  40	  minutes,	  the	  clamps	  were	  
removed	  to	  restore	  renal	  blood	  flow	  and	  the	  animals	  were	  allowed	  to	  fully	  recover.	  8	  
hours	  post	  surgery,	  the	  rats	  were	  injected	  subcutaneously	  with	  buponorphine	  
(0.05mg/kg)	  to	  manage	  pain.	  	  
	  
	  
2.7.2 Unilateral	  Clamp	  Model	  
Rats	  were	  anesthetized	  with	  intraperitoneal	  injections	  of	  50mg/kg	  pentobarbital	  
(Hospira,	  Inc,	  Lake	  Forest,	  IL	  and	  Custom	  Med	  Apothecary,	  Indianapolis,	  IN)	  or	  ketamine	  
xylazine	  ace	  cocktail	  and	  placed	  on	  a	  heating	  pad	  to	  maintain	  normal	  physiological	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temperature.	  Using	  a	  standard	  model	  to	  general	  renal	  ischemia-­‐reperfusion	  injury,	  the	  
left	  renal	  pedicle	  were	  clamped	  with	  a	  microserrefine	  clamp	  (Fine	  Science	  Tools,	  Foster	  
City,	  CA)	  to	  occlude	  blood	  flow	  for	  a	  period	  of	  40	  minutes,	  which	  corresponds	  to	  
moderate	  acute	  kidney	  injury.	  At	  the	  end	  of	  each	  injury	  period,	  the	  clamp	  was	  removed	  
to	  reinstate	  renal	  blood	  flow	  according	  to	  reperfusion	  model.	  	  
	  
	  
2.7.3 Ischemic	  Preconditioning	  
Rats	  were	  again	  anesthetized	  in	  the	  manner	  described	  above	  and	  subjected	  to	  
unilateral	  pedicle	  clamps	  to	  occlude	  renal	  blood	  flow	  for	  a	  period	  of	  40	  minute.	  The	  
incisions	  were	  temporarily	  closed	  during	  ischemia.	  After	  40	  minutes,	  the	  clamp	  was	  
removed	  to	  reinstate	  renal	  blood	  flow	  for	  1	  hour	  before	  the	  kidneys	  were	  removed	  and	  
the	  rats	  sacrificed.	  	  
	  
	  




2.8.1 Retrograde	  Renal	  Fine-­‐Needle	  Injection	  with	  Vascular	  Clamps	  
Rats	  were	  anesthetized	  by	  inhaled	  isoflurane	  (5%	  in	  oxygen,	  Webster	  Veterinary	  
Supply,	  Devens,	  MA)	  and	  then	  placed	  on	  a	  heating	  pad	  to	  maintain	  normal	  physiological	  
temperature.	  Once	  the	  animal	  was	  fully	  sedated,	  the	  abdominal	  region	  was	  shaved	  and	  
sanitized	  with	  Betadine	  Surgical	  Scrub	  (Purdue	  Products	  L.P.,	  Stamford,	  CT)	  solution.	  It	  
was	  then	  restrained	  on	  a	  heating	  pad.	  A	  midline	  incision	  was	  made	  to	  expose	  the	  left	  
kidney.	  The	  renal	  artery	  and	  vein	  were	  separated	  and	  the	  renal	  artery	  was	  clamped	  first	  
before	  the	  renal	  vein	  was	  clamped	  using	  micro-­‐serrefines.	  The	  vein	  was	  isolated	  with	  a	  
3-­‐0	  silk	  loop	  and	  elevated.	  We	  performed	  a	  retrograde	  infusion	  of	  either	  tissue	  dye	  or	  
transgenes	  at	  an	  approximate	  rate	  of	  0.1ml/s	  into	  the	  renal	  vein,	  using	  a	  30-­‐gauge	  
needle.	  We	  then	  removed	  the	  needle	  and	  applied	  pressure	  to	  the	  injection	  site,	  with	  a	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cotton	  swab	  to	  induce	  hemostasis.	  	  The	  clamps	  were	  then	  removed	  (venous	  before	  
arterial	  clamp)	  to	  restore	  renal	  blood	  flow.	  The	  total	  clamping	  period	  lasted	  3	  minutes.	  
The	  midline	  incision	  was	  closed	  and	  the	  animal	  was	  allowed	  to	  fully	  recover.	  8	  hours	  
post	  surgery;	  the	  rats	  were	  injected	  with	  buponorphine.	  	  
	  
	  
Figure	  6:	  Schematic	  of	  hydrodynamic	  fluid	  delivery	  with	  vascular	  cross	  clamps[137].	  
	  
	  
2.8.2 Parameter	  for	  Successful	  Retrograde	  Renal	  Vein	  Hydrodynamic	  Injection:	  
Pressure	  Profile	  
To	  characterize	  the	  hydrodynamic	  delivery	  process	  and	  measure	  pressure	  changes	  
within	  the	  renal	  vein,	  we	  monitored	  time-­‐dependent	  pressure	  profiles	  during	  the	  
hydrodynamic	  injections.	  A	  modified	  double	  30-­‐gauge	  needle	  was	  used	  to	  connect	  the	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needle	  to	  a	  fluid-­‐filled	  pressure	  transducer	  and	  data	  was	  acquired	  in	  real	  time	  using	  
data-­‐acquisition	  software	  (Biopac	  Systems,	  Inc.,	  Goleta,	  CA).	  
	  
	  
2.9 Western	  Blot	  Analysis	  
Whole	  kidneys	  were	  extracted	  from	  anesthetized	  rats,	  which	  were	  then	  euthanized.	  
The	  cortex	  from	  the	  kidney	  was	  excised	  and	  homogenized	  in	  RIPA	  buffer	  (150mM	  NaCl,	  
50mM	  Tris-­‐Cl	  pH	  8.0,	  1%	  Triton	  X-­‐100,	  0.5%	  Sodium	  Deoxycholate,	  0.1%	  SDS).	  The	  
samples	  were	  then	  sonicated	  	  and	  centrifuged.	  The	  extracts	  (3-­‐15μg/lane)	  were	  
separated	  through	  the	  10%	  Tris-­‐Glycine	  Mini	  Gels,	  along	  with	  4μl	  molecular	  weight	  
markers	  (Precision	  Plus	  Protein	  TM	  Dual	  Color	  Standards,	  BIO-­‐RAD,	  Cat.	  #616-­‐0374).	  
Proteins	  were	  electroblotted	  to	  nitrocellulose	  membranes.	  The	  membrane	  was	  blocked	  
by	  incubation	  in	  TBS	  with	  3%	  FBS	  for	  1hr	  at	  room	  temperature.	  Membranes	  were	  
incubated	  with	  primary	  antibody	  in	  TBS	  with	  0.3%	  FBS	  for	  1hour	  at	  room	  temperature.	  
After	  three	  washes	  at	  5mins	  each,	  the	  membrane	  was	  incubated	  with	  appropriate	  IRDye	  
fluorescent	  secondary	  antibody	  	  (LI-­‐COR,	  Lincoln,	  NE)	  in	  antibody	  dilution	  buffer	  at	  room	  
temperature	  for	  1	  hour.	  After	  three	  washes	  each	  5mins,	  the	  blots	  were	  dried	  overnight	  
in	  a	  black	  box.	  The	  next	  day,	  the	  blots	  were	  imaged	  using	  the	  LiCor	  system.	  
	  
	  




2.10.1 Extracting	  the	  Kidneys	  
The	  rats	  were	  anesthetized	  with	  either	  pentobarbital	  or	  ketamine	  xylazine	  ace	  
cocktail.	  A	  midline	  incision	  on	  the	  abdomen	  is	  made	  and	  the	  appropriate	  injury	  
performed	  on	  the	  left	  or	  right	  kidney.	  At	  the	  end,	  the	  rat	  is	  euthanized.	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2.10.2 Homogenization	  
After	  the	  kidney	  was	  harvested	  from	  the	  rat,	  the	  capsule	  layer	  was	  peeled	  and	  
the	  cortex	  was	  shaved	  off.	  At	  4°C,	  the	  cortex	  was	  gently	  homogenized	  at	  370	  rpm	  with	  a	  
tight	  fitting	  homogenizer	  in	  1ml	  mitochondrial	  lysis	  buffer	  (250mM	  sucrose,	  20mM	  
HEPES,	  10mM	  KCl,	  1.5	  mM	  Mg2Cl,	  1.0mM	  EDTA,	  pH	  7.9)	  using	  a	  Wheaton	  Teflon	  pestle	  
and	  15mL	  homogenization	  tube.	  
	  
	  
2.10.3 Mitochondria	  Purification	  
The	  homogenate	  was	  spun	  at	  800g	  for	  10mins	  at	  4°C.	  The	  supernatant	  was	  
transferred	  to	  another	  microcentrifuge	  tube	  and	  spun	  at	  10000xg	  for	  10mins	  4°C.	  	  The	  
supernatant	  was	  discarded	  and	  the	  pellet	  was	  resuspended	  in	  1mL	  of	  Lysis	  buffer.	  The	  
process	  was	  repeated	  for	  3	  washes	  with	  the	  Lysis	  buffer	  and	  kept	  on	  ice	  with	  caps	  open	  
at	  the	  end	  of	  the	  purification.	  The	  concentration	  of	  mitochondria	  fraction	  was	  




2.10.4 Mitochondria	  Oxygen	  Concentration	  Measurement	  
Before	  commencing	  each	  set	  of	  mitochondrial	  fractions,	  the	  oxygen	  electrode	  of	  
the	  Oxygen	  Meter	  (Model	  5300,	  Yellow	  Springs	  Instrument	  Co.)	  was	  calibrated	  and	  the	  
membrane	  changed.	  The	  chambers	  for	  each	  sample	  were	  surrounded	  by	  a	  temperature-­‐
controlled	  water-­‐jacketed	  glass	  chamber	  maintaining	  the	  temperature	  at	  37°C.	  	  
	  
The	  mitochondrial	  fraction	  for	  each	  kidney	  was	  divided	  into	  3	  portions	  (roughly	  
350μL)	  and	  each	  portion	  was	  added	  to	  the	  oxygen	  chamber	  with	  2.2mL	  of	  terzic	  Buffer	  
(110mM	  KCl,	  5mM	  K2HPO4·∙3H2O,	  10mM	  MOPS,	  10mM	  Mg·∙Acetate,	  1mM	  EDTA,	  1μM	  
tetrasodium	  pyrophosphate,	  0.1%	  BSA,	  pH	  7.15)	  for	  a	  total	  volume	  of	  2.5mL.	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The	  electrode	  was	  gently	  inserted	  into	  the	  chamber,	  making	  sure	  that	  there	  was	  no	  
air	  bubbles	  visible	  in	  the	  chamber.	  The	  stir	  bar	  was	  turned	  on	  and	  the	  oxygen	  
percentage	  was	  recorded	  when	  the	  0.1	  ml	  of	  the	  following	  substances	  was	  added	  every	  
1-­‐minute	  in	  the	  following	  order:	  Terzic	  buffer	  (as	  blank),	  substrate	  (1M	  succinate	  or	  1M	  
isocitrate	  or	  1M	  pyruvate),	  and	  ADP	  (25mM).	  The	  substances	  were	  injected	  by	  23-­‐gauge	  
syringed	  attached	  to	  PE-­‐50	  tubing	  to	  give	  a	  final	  concentration	  of	  10mM	  in	  the	  chamber.	  
At	  10minutes,	  the	  recording	  of	  the	  mitochondria	  oxygen	  respiration	  was	  stopped.	  	  
	  
	  
2.11 Statistical	  Analysis	  
We	  computed	  the	  mean	  and	  S.E.	  for	  all	  data	  sets,	  and	  evaluated	  the	  statistical	  
significance	  of	  our	  results	  using	  the	  Student’s	  t-­‐test.	  All	  statistical	  analyses	  were	  
evaluated	  using	  95%	  confidence	  threshold.	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3.1 Ischemic	  Preconditioning	  Protects	  Sprague	  Dawley	  Rat	  Kidney	  Mitochondria	  Against	  
Dysfunction	  Following	  Moderate	  Ischemic/Reperfusion	  Injury	  
We	  first	  investigated	  the	  effect	  of	  ischemic	  preconditioning	  on	  respiration	  rates	  in	  
mitochondria	  isolated	  from	  the	  kidney	  cortex.	  For	  the	  preconditioning	  part	  of	  the	  study,	  
there	  are	  in	  total	  of	  six	  groups	  of	  kidney	  cortex	  samples	  (Table	  2).	  Preconditioning	  was	  
induced	  by	  clamping	  the	  pedicle	  of	  both	  kidneys	  for	  40	  minutes.	  Subsequently,	  animals	  
were	  subjected	  to	  bilateral	  or	  unilateral	  ischemia	  using	  the	  same	  procedure.	  Sham	  
surgery	  was	  used	  as	  a	  control.	  Sham	  Sham	  (SS)	  rats	  underwent	  sham	  surgery	  at	  day	  0	  
and	  at	  day	  14,	  both	  right	  and	  left	  kidneys	  are	  accorded	  the	  same	  treatment	  and	  
manipulation.	  In	  the	  PC	  Uni	  group,	  rats	  underwent	  bilateral	  ischemic	  reperfusion	  injury	  
(IRI)	  at	  day	  0,	  and	  unilateral	  left	  kidney	  IRI	  at	  day	  14	  before	  sacrifice.	  In	  the	  PC	  Bi	  group,	  
rats	  underwent	  bilateral	  ischemic	  reperfusion	  injury	  (IRI)	  at	  day	  0,	  and	  bilateral	  kidney	  
IRI	  at	  day	  14	  before	  sacrifice.	  In	  the	  PC	  S	  group,	  the	  kidneys	  are	  the	  right	  kidneys	  of	  the	  
PC	  Uni	  group,	  which	  underwent	  bilateral	  ischemic	  reperfusion	  injury	  (IRI)	  at	  day	  0	  and	  
sham	  injury	  at	  day	  14	  before	  sacrifice.	  In	  the	  SI	  Uni	  group,	  rats	  underwent	  sham	  surgery	  
at	  day	  0	  and	  unilateral	  left	  IRI	  at	  day	  14.	  In	  the	  SI	  Bi	  group,	  rats	  underwent	  sham	  surgery	  
at	  day	  0	  and	  bilateral	  IRI	  at	  day	  14.	  All	  IRIs	  are	  40	  minutes	  ischemia	  followed	  by	  a	  1	  hour	  
reperfusion	  unless	  stated	  otherwise.	  The	  vehicle	  without	  Injury,	  vehicle	  with	  injury	  and	  
IDH2	  groups	  are	  data	  from	  a	  previous	  thesis	  by	  Shijun	  Zhang	  [172].	  Mitochondrial	  
fractions	  were	  isolated	  from	  the	  cortices	  of	  each	  kidney	  and	  mitochondria	  are	  purified	  
from	  these	  cortices	  to	  be	  used	  in	  the	  mitochondrial	  oxygen	  consumption	  assay.	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Table	  3:	  Summary	  of	  the	  different	  preconditioning	  study	  rat	  groups.	  
Group	   Group	  
Abbreviation	  
Surgery	  at	  Day	  
0	  
Surgery	  at	  Day	  14	   n	  




PC	  Uni	   40min	  bilateral	  
renal	  pedicle	  
clamps	  
40	  min	  unilateral	  







PC	  Bi	   40min	  bilateral	  
renal	  pedicle	  
clamps	  
40	  min	  bilateral	  
renal	  pedicle	  






PC	  S	   40min	  bilateral	  
renal	  pedicle	  
clamps	  
Sham	   12	  
Sham	  Injury	  
(Unilateral)	  
SI	  Uni	   Sham	   40	  min	  unilateral	  






SI	  Bi	   Sham	   40	  min	  bilateral	  
renal	  pedicle	  
clamps,	  1	  hr.	  
reperfusion	  
8	  
#	  -­‐	  Data	  includes	  both	  left	  and	  right	  kidneys.	  *	  -­‐	  Data	  is	  derived	  from	  right	  kidney	  of	  PC	  
Uni	  rats,	  right	  kidneys	  are	  not	  injured	  at	  day	  14.	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Table	  4:	  Summary	  of	  the	  different	  hydrodynamic	  injection	  study	  rat	  groups.	  
Group	   Group	  
Abbreviation	  






VwoI	   0.5ml	  of	  Saline,	  
hydrodynamically	  
injected	  
Sham	   9	  
Vehicle	  
with	  Injury	  


















We	  measured	  serum	  creatinine	  values	  following	  preconditioning	  or	  sham	  surgery,	  to	  
determine	  that	  the	  desired	  degree	  of	  injury	  had	  been	  achieved,	  with	  a	  rise	  in	  serum	  
creatinine	  indicative	  of	  moderate	  AKI.	  The	  serum	  creatinine	  values	  for	  each	  of	  the	  
Preconditioning	  study	  groups	  are	  checked	  at	  day	  1,	  2,	  7	  and	  14.	  Serum	  creatinine	  is	  not	  
taken	  for	  hydrodynamic	  injection	  study	  groups.	  For	  all	  the	  preconditioning	  study	  groups,	  
serum	  creatinine	  levels	  are	  elevated	  and	  the	  averages	  for	  each	  time	  point	  are	  shown	  in	  
figure	  6	  and	  7.	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Figure	  7:	  Serum	  creatinine	  values	  of	  SS,	  PC	  Uni	  and	  SI	  Uni	  groups	  over	  14	  days.	  
	  
	  
















Serum	  Creatinine	  for	  Preconditioned	  Groups	  
1hr	  Reperfusion	  Unilateral	  2nd	  Injury	  










Serum	  Creatinine	  for	  Preconditioned	  Groups	  
1hr	  Reperfusion	  Bilateral	  2nd	  Injury	  
Sham	  Sham	  SS	  Sham	  w	  2nd	  Injury	  SI	  Bi	  Precondition	  PC	  Bi	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Mitochondrial	  respiration	  was	  assayed	  using	  three	  different	  substrates	  that	  enter	  
the	  Krebs	  cycle	  at	  different	  points.	  Using	  these	  substrates,	  the	  mitochondria	  oxygen	  
consumption	  is	  measured	  at	  State	  III	  in	  the	  respiration	  cycle.	  The	  respiration	  rates	  of	  all	  
groups	  are	  shown	  in	  Figure	  8,	  and	  broken	  down	  in	  analysis	  subsequently.	  A	  respiration	  
control	  index	  (ratio	  of	  State	  III	  to	  State	  IV)	  is	  unable	  to	  be	  achieved	  by	  the	  equipment	  
used	  in	  this	  set	  of	  studies,	  but	  can	  be	  calculated	  with	  a	  more	  refined	  protocol	  and	  more	  
advanced	  machines,	  namely	  the	  Oroboros	  O2k	  machine	  (Bioblast,	  Innsbruck,	  Austria)	  or	  
Seahorse	  XF	  Analyzer	  (Seahorse	  Bioscience,	  North	  Billerica,	  MA).	  The	  results	  of	  the	  
mitochondria	  respiration	  assay	  can	  be	  broken	  down	  into	  various	  comparisons	  among	  
the	  above-­‐described	  groups	  of	  kidneys.	  	  
	  
	  
Figure	  9:	  Summary	  of	  all	  respiration	  rates	  of	  all	  groups	  of	  rat	  renal	  cortex	  mitochondria	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Figure	  9:	  Summary	  of	  all	  respiration	  rates	  of	  all	  groups	  of	  rat	  renal	  cortex	  mitochondria	  
fractions	  on	  a	  logarithmic	  scale	  (continued).	  	  
	  
Figure	  9:	  Graph	  8a	  corresponds	  respiration	  rates	  of	  renal	  mitochondria	  with	  the	  
substrate	  succinate	  added	  at	  t=1min,	  Graph	  8b	  corresponds	  to	  the	  substrate	  isocitrate	  
added	  at	  t=1min	  and	  graph	  8c	  corresponds	  to	  the	  substrate	  pyruvate	  added	  at	  t=1min.	  
Oxygen	  consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  
milligram	  of	  mitochondria	  protein	  (as	  determined	  from	  the	  Bradford	  Assay).	  Refer	  to	  
table	  2	  and	  3	  for	  legend	  and	  n.	  All	  brackets	  over	  pairs	  of	  data	  values	  denote	  a	  significant	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3.1.1 Sham	  unilateral	  injury	  (SI	  Uni)	  rat	  renal	  mitochondria	  respiration	  rates	  are	  
depressed	  as	  compared	  to	  Sham	  Sham	  renal	  mitochondria	  respiration	  rates	  for	  
all	  substrates.	  
For	  all	  substrates,	  SI	  Uni	  mitochondria	  respiration	  rates	  are	  significantly	  different	  
from	  SI	  Bi	  mitochondria	  respiration	  rates	  (p<0.05).	  SI	  Bi	  mitochondria	  respiration	  rate	  is	  
significantly	  elevated	  above	  that	  of	  sham	  group	  SS	  (p<0.05)	  and	  SI	  Uni	  mitochondria	  
respiration	  rate	  is	  significantly	  depressed	  compared	  to	  that	  of	  sham	  group	  (p<0.05).	  	  
	  
Figure	  10:	  Comparison	  of	  respiration	  rates	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  the	  
two	  sham	  injury	  (SI)	  groups	  for	  the	  substrate	  Succinate	  on	  a	  logarithmic	  scale.	  	  
	  
Sham,	  Unilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (SI	  Uni)	  and	  Sham,	  
Bilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (SI	  Bi).	  *,	  **	  -­‐	  The	  SI	  Uni	  and	  
SI	  Bi	  group	  are	  both	  significantly	  different	  from	  the	  SS	  group	  (p<0.05).	  Oxygen	  
consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  milligram	  of	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Figure	  11:	  Comparison	  of	  respiration	  rates	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  the	  
two	  sham	  injury	  (SI)	  groups	  for	  the	  substrate	  Isocitrate	  on	  a	  logarithmic	  scale.	  
Sham,	  Unilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (SI	  Uni)	  and	  Sham,	  
Bilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (SI	  Bi).	  The	  SI	  Uni	  and	  SI	  Bi	  
group	  are	  both	  significantly	  different	  from	  the	  SS	  group	  (*,	  **	  p<0.05).	  Oxygen	  
consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  milligram	  of	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Figure	  12:	  Comparison	  of	  respiration	  rates	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  the	  
two	  sham	  injury	  (SI)	  for	  the	  substrate	  Pyruvate	  on	  a	  logarithmic	  scale.	  
Sham,	  Unilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (SI	  Uni)	  and	  Sham,	  
Bilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (SI	  Bi).	  The	  SI	  Uni	  and	  SI	  Bi	  
group	  are	  both	  significantly	  different	  from	  the	  SS	  group	  (*,**	  p<0.05).	  Oxygen	  
consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  milligram	  of	  
mitochondria	  protein	  (as	  determined	  from	  the	  Bradford	  Assay).	  SS	  n=27,	  SI	  Uni	  n=9,	  SI	  Bi	  
b=8.	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3.1.2 Preconditioned	  Unilaterally	  and	  Bilaterally	  Injured	  Rat	  Renal	  Mitochondria	  
respire	  similar	  or	  as	  compared	  to	  sham	  sham	  rat	  renal	  mitochondria	  for	  two	  
substrates:	  succinate	  and	  pyruvate.	  
Using	  succinate	  as	  a	  substrate,	  after	  ischemic	  reperfusion	  injury	  (IRI),	  mitochondria	  
respiration	  of	  preconditioned	  unilaterally	  injured	  rat	  renal	  mitochondria	  (PC	  Uni)	  and	  
preconditioned	  bilaterally	  injured	  rat	  renal	  mitochondria	  (PC	  Bi)	  are	  performing	  on	  a	  
similar	  level	  to	  sham	  sham	  (SS)	  renal	  mitochondria	  (p>0.05).	  The	  PC	  Uni	  and	  PC	  Bi	  
mitochondria	  has	  endured	  not	  one	  but	  two	  separate	  events	  of	  moderate	  ischemic	  injury	  
and	  yet,	  the	  mitochondria	  respiration	  for	  these	  PC	  groups	  compared	  to	  sham	  group	  SS	  is	  
indistinguishable.	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Figure	  13:	  Comparison	  of	  respiration	  rates	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  the	  
two	  preconditioned	  groups	  for	  the	  substrate	  succinate	  on	  a	  logarithmic	  scale.	  
Preconditioned,	  Unilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (PC	  Uni)	  
and	  Preconditioned,	  Bilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (PC	  Bi).	  
*,	  **	  -­‐	  There	  are	  no	  differences	  between	  the	  SS	  group	  and	  each	  PC	  group	  (p>0.05).	  
Oxygen	  consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  
milligram	  of	  mitochondria	  protein	  (as	  determined	  from	  the	  Bradford	  Assay).	  SS	  n=27,	  PC	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Figure	  14:	  Comparison	  of	  respiration	  rates	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  the	  
two	  preconditioned	  group	  for	  the	  substrate	  Isocitrate	  on	  a	  logarithmic	  scale.	  
Preconditioned,	  Unilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (PC	  Uni)	  
and	  Preconditioned,	  Bilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (PC	  Bi).	  
There	  is	  a	  significant	  difference	  between	  the	  SS	  group	  and	  PC	  Uni	  group	  (*,	  p<0.05).	  
There	  is	  no	  difference	  between	  the	  SS	  group	  and	  PC	  Bi	  group	  (**,	  p>0.05).	  Oxygen	  
consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  milligram	  of	  
mitochondria	  protein	  (as	  determined	  from	  the	  Bradford	  Assay).	  SS	  n=27,	  PC	  Uni	  n=12,	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Figure	  15:	  Comparison	  of	  respiration	  rate	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  the	  two	  
preconditioned	  groups	  for	  substrate	  pyruvate	  on	  a	  logarithmic	  scale.	  	  
Preconditioned,	  unilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (PC	  Uni)	  
and	  preconditioned,	  bilaterally	  injured	  rat	  kidney	  cortex	  mitochondria	  fractions	  (PC	  Bi).	  
There	  are	  no	  differences	  between	  the	  SS	  group	  and	  PC	  Uni	  group	  (*,	  p>0.05),	  and	  there	  
is	  a	  difference	  between	  the	  SS	  group	  and	  PC	  Bi	  group	  (**,	  p<0.05).	  Oxygen	  consumption	  
is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  milligram	  of	  mitochondria	  
protein	  (as	  determined	  from	  the	  Bradford	  Assay).	  SS	  n=27,	  PC	  Uni	  n=12,	  PC	  Bi	  n=10.	  
	  
Using	  pyruvate	  as	  a	  substrate,	  after	  IRI,	  mitochondria	  respiration	  of	  PC	  Uni	  
mitochondria	  is	  respiring	  no	  different	  from	  SS	  mitochondria	  (p>0.05)	  and	  PC	  Bi	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   For	  the	  substrate	  succinate,	  SS	  mitochondria	  respiration	  rate	  is	  similar	  to	  that	  of	  
vehicle	  (saline)	  injected	  mitochondria	  (without	  IRI)	  (p>0.05).	  For	  the	  other	  two	  
substrates,	  isocitrate	  and	  pyruvate,	  respiration	  rates	  of	  VwoI	  mitochondria	  are	  
significantly	  depressed	  compared	  to	  SS	  mitochondria	  (p<0.05).	  With	  SS	  mitochondria	  as	  
a	  baseline	  control	  group,	  	  
	  
	  
Figure	  16:	  Comparison	  of	  respiration	  rates	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  all	  the	  
injection	  groups,	  vehicle	  without	  injury,	  vehicle	  with	  injury	  and	  IDH2	  for	  the	  substrate	  
Succinate	  on	  a	  logarithmic	  scale.	  	  
Oxygen	  consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  
milligram	  of	  mitochondria	  protein	  (as	  determined	  from	  the	  Bradford	  Assay).	  *	  -­‐	  No	  
difference	  between	  SS	  and	  VwoI	  groups.	  **	  -­‐	  Significant	  difference	  between	  IDH2	  and	  VI	  






SS	   VwoI	   VI	   IDH2	  log(µ
M	  O 2	  ·	  m




Respiration:	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3.1.1 Sham	  Sham	  rat	  renal	  mitochondria	  respiration	  rate	  is	  similar	  to	  vehicle	  
injected	  without	  IRI	  rat	  renal	  mitochondria	  only	  for	  one	  substrate	  succinate	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Figure	  17:	  Comparison	  of	  respiration	  rates	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  all	  the	  
injection	  groups,	  vehicle	  without	  injury,	  vehicle	  with	  injury	  and	  IDH2	  for	  the	  substrate	  
Isocitrate	  on	  a	  logarithmic	  scale.	  	  
Oxygen	  consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  
milligram	  of	  mitochondria	  protein	  (as	  determined	  from	  the	  Bradford	  Assay).	  *	  -­‐	  
Significant	  difference	  between	  SS	  and	  VwoI	  groups.	  **	  -­‐	  Significant	  difference	  between	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Figure	  18:	  Comparison	  of	  respiration	  rates	  of	  Sham	  Sham	  (SS)	  group	  compared	  to	  all	  the	  
injection	  groups,	  vehicle	  without	  injury,	  vehicle	  with	  injury	  and	  IDH2	  for	  the	  substrate	  
Pyruvate	  on	  a	  logarithmic	  scale.	  	  
Oxygen	  consumption	  is	  measured	  in	  micromole	  oxygen	  consumed	  per	  minute,	  per	  
milligram	  of	  mitochondria	  protein	  (as	  determined	  from	  the	  Bradford	  Assay).	  *	  -­‐	  
Significant	  difference	  between	  SS	  and	  VwoI	  groups.	  **	  -­‐	  Significant	  difference	  between	  
VI	  and	  IDH2	  groups	  (from	  Shijun	  Zhang’s	  thesis).	  SS	  n=27,	  VwoI	  n=9,	  VI	  n=9,	  IDH2	  n=9.	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3.1.3 EGTA	  as	  an	  ingredient	  in	  Terzic	  buffer	  allows	  for	  improved	  respiration	  as	  
compared	  to	  EDTA	  
In	  the	  buffer	  used	  for	  the	  respiration	  chamber,	  we	  used	  EDTA	  as	  an	  ingredient	  
but	  a	  review	  of	  the	  protocol	  revealed	  that	  EGTA	  could	  possibly	  be	  a	  better	  ingredient.	  
Both	  EDTA	  and	  EGTA	  chelate	  for	  both	  calcium	  and	  magnesium,	  but	  EDTA	  has	  a	  higher	  
affinity	  for	  chelating	  magnesium,	  an	  important	  cofactor	  for	  the	  proper	  function	  of	  
isocitrate	  dehydrogenase	  2,	  our	  protein	  of	  interest.	  EGTA	  has	  a	  lower	  affinity	  for	  
magnesium	  and	  a	  high	  affinity	  for	  calcium.	  Our	  results	  revealed	  that	  there	  is	  a	  significant	  
difference	  in	  respiration	  rates	  for	  EDTA	  compared	  to	  EGTA	  buffers	  for	  the	  substrate	  
succinate	  but	  a	  negligible	  difference	  for	  respiration	  for	  the	  substrates	  isocitrate	  and	  
pyruvate.	  
	  
Figure	  19:	  Comparison	  of	  EDTA	  vs.	  EGTA	  as	  an	  ingredient	  in	  Terzic	  buffer	  for	  the	  
substrate	  Succinate.	  
EGTA	  used	  in	  the	  terzic	  buffer	  resulted	  in	  a	  significantly	  improved	  respiration	  rate	  (*,	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Figure	  20:	  Comparison	  of	  EDTA	  vs.	  EGTA	  as	  an	  ingredient	  in	  Terzic	  buffer	  for	  the	  
substrates	  Isocitrate	  (a)	  and	  Pyruvate	  (b).	  
EGTA	  used	  in	  the	  terzic	  buffer	  resulted	  in	  similar	  respiration	  rates	  (p<0.05)	  compared	  to	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3.2 Western	  blot	  analysis	  of	  IDH2	  protein	  in	  Preconditioned	  samples	  shows	  elevated	  
IDH2	  levels	  in	  Sham	  injury	  bilateral	  (SI	  Bi),	  Preconditioned	  Unilaterally	  injured	  (PC	  




Figure	  21:	  Quantification	  of	  IDH2	  protein	  expression	  in	  Preconditioned	  study	  groups	  via	  
Western	  blot	  analysis.	  
The	  amount	  of	  IDH2	  in	  Preconditioned	  rat	  kidney	  groups	  were	  quantified	  and	  compared	  
to	  the	  control	  group	  (SS).	  Analyses	  of	  band	  intensity	  on	  films	  are	  presented	  as	  a	  ratio	  
relative	  to	  actin	  intensities.	  	  
Western	  blot	  analysis	  on	  IDH2	  versus	  Actin	  fluorescent	  intensities	  showed	  that	  the	  
levels	  of	  IDH2	  proteins	  are	  depressed	  in	  PC	  Uni,	  PC	  Bi	  and	  SI	  Uni	  groups	  while	  SI	  Bi	  group	  
has	  increased	  IDH2	  protein.	  The	  increase	  or	  decrease	  in	  IDH2	  protein	  levels	  show	  that	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3.3 Hydrodynamically	  Delivered	  Mitochondrial	  Protein	  IDH2	  Protects	  Rat	  Kidney	  
Mitochondria	  against	  Moderate	  Ischemic/Reperfusion	  Injury	  
In	  this	  procedure,	  there	  were	  three	  groups	  of	  rats:	  two	  of	  which	  received	  
hydrodynamic	  delivery	  of	  saline	  only	  (VwoI	  and	  VI),	  and	  one	  of	  which	  received	  
hydrodynamic	  delivery	  of	  IDH2	  plasmid	  (IDH2).	  At	  7	  days	  post	  injection,	  one	  of	  the	  
vehicle	  groups	  (VI)	  and	  the	  IDH2	  group	  received	  a	  40-­‐minute	  unilateral	  ischemia	  to	  the	  
same	  kidney	  that	  was	  injected	  with	  the	  respective	  solution,	  followed	  by	  a	  1-­‐hour	  
reperfusion.	  The	  last	  group	  (VwoI)	  was	  sacrificed	  without	  injury.	  Kidney	  tissues	  were	  
harvested	  from	  all	  three	  groups	  and	  the	  mitochondrial	  fractions	  isolated	  from	  the	  
kidney	  tissue.	  Mitochondrial	  fractions	  were	  then	  used	  in	  the	  mitochondrial	  oxygen	  
consumption	  assay.	  	  
	  
After	  ischemia	  reperfusion	  injury	  (IRI),	  mitochondrial	  oxygen	  consumption	  of	  
each	  fraction	  in	  state	  III	  was	  measured	  based	  on	  the	  Chance	  and	  Wooden	  protocol[170].	  
The	  results	  of	  the	  oxygen	  consumption	  assay	  are	  shown.	  For	  the	  substrate	  succinate,	  
mitochondrial	  oxygen	  consumption	  of	  IDH2	  injected	  rats	  (IDH2)	  had	  no	  significant	  
difference	  from	  vehicle	  rats	  without	  injury	  (VWOI),	  p>0.05,	  but	  significantly	  different,	  
p<0.05,	  from	  vehicle	  with	  injury	  group	  (VI).	  IDH2	  group’s	  oxygen	  consumption	  remains	  
slightly	  depressed	  from	  the	  VWOI	  group.	  	  
	  
For	  the	  substrate	  pyruvate,	  mitochondrial	  oxygen	  consumption	  of	  IDH2	  injected	  
rats	  (IDH2)	  receiving	  IRI	  had	  no	  significant	  difference	  from	  vehicle	  rats	  without	  injury	  
(VWOI),	  p>0.05,	  but	  significantly	  different,	  p<0.05,	  from	  vehicle	  with	  injury	  group	  (VI).	  
IDH2	  group’s	  oxygen	  consumption	  remains	  slightly	  depressed	  from	  the	  VWOI	  group.	  The	  
upregulation	  of	  IDH2	  in	  IDH2	  injected	  rats	  is	  confirmed	  via	  western	  blot	  analysis,	  with	  a	  
significant	  increase	  of	  IDH2	  in	  IDH2	  injected	  rats	  compared	  to	  VWOI	  and	  VI	  rats.	  	  
	  
Thus,	  upregulation	  of	  IDH2	  in	  hydrodynamically	  gene	  delivered	  kidneys	  resulted	  
in	  improved	  mitochondrial	  oxygen	  consumption	  compared	  to	  VI	  or	  injured	  rats.	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Mitochondria	  oxygen	  consumption	  was	  significantly	  impaired	  after	  IRI	  injury,	  but	  the	  
overexpression	  of	  IDH2	  genes	  ameliorated	  the	  decrease	  in	  oxygen	  consumption.	  This	  
protective	  effect	  is	  analogous	  to	  the	  protective	  effect	  of	  preconditioning	  observed	  in	  
previous	  studies	  comparing	  serum	  creatinine	  values.	  	  
	  
	  
3.3.1 Overexpression	  of	  transgene	  confirmed	  via	  western	  blot	  analysis	  
In	  total,	  there	  were	  six	  groups	  of	  rat	  kidney	  cortex	  samples.	  One	  group,	  sham	  (SS)	  
rats	  underwent	  sham	  surgery	  at	  both	  day	  0	  and	  day	  14,	  sham	  injury	  rats	  underwent	  
sham	  surgery	  at	  day	  0	  and	  IRI	  surgery	  at	  day	  14,	  preconditioned	  rats	  (PC)	  underwent	  IRI	  
surgery	  at	  both	  day	  0	  and	  day	  14,	  vehicle	  without	  injury	  rats	  underwent	  
hydrodynamically	  injected	  saline	  injection	  at	  day	  0	  and	  sham	  surgery	  at	  day	  7,	  vehicle	  
with	  injury	  rats	  underwent	  hydrodynamically	  injected	  saline	  injection	  at	  day	  0	  and	  IRI	  
surgery	  at	  day	  7	  while	  IDH2	  rats	  underwent	  hydrodynamically	  injected	  IDH2	  injection	  at	  
day	  0	  and	  IRI	  surgery	  at	  day	  7.	  There	  were	  increased	  levels	  of	  IDH2	  expression	  in	  rats	  
that	  received	  hydrodynamic	  delivery	  of	  the	  IDH2	  plasmids,	  compared	  to	  the	  vehicle	  rats.	  
By	  densitometry	  analysis	  of	  the	  western	  blot,	  IDH2	  expression	  in	  the	  IDH2	  delivered	  rats	  
was	  2.2	  times	  higher	  than	  VWOI	  rats.	  The	  IDH2	  expression	  of	  PC	  rats	  were	  2.8	  times	  
higher	  than	  SS	  rats,	  only	  for	  bilaterally	  injured	  animals	  and	  1.6	  times	  higher	  than	  SS	  rats	  
for	  unilaterally	  injured	  animals.	  The	  western	  blot	  analysis	  shows	  that	  there	  is	  
upregulation	  of	  IDH2	  enzymes	  through	  hydrodynamic	  injection	  and	  through	  bilateral	  
ischemic	  preconditioning.	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Figure	  22:	  Quantification	  of	  IDH2	  protein	  expression	  in	  rat	  kidneys	  via	  Western	  blot	  
analysis.	  
	  The	  amount	  of	  IDH2	  in	  IDH2	  delivery	  rat	  kidneys	  and	  Preconditioned	  rat	  kidneys	  were	  
quantified	  and	  compared	  to	  the	  control	  group	  (saline	  injected).	  Analyses	  of	  band	  
intensity	  on	  films	  are	  presented	  as	  a	  ratio	  relative	  to	  actin	  intensities.	  *P>0.05	  compared	  
to	  Preconditioned.	  #P<0.05	  compared	  to	  Control	  (saline	  injected).	  Taken	  from	  Shijun	  
Zhang’s	  thesis	  [172]	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3.4 Morphology	  of	  each	  group	  of	  mitochondria	  under	  Electron	  Microscopy	  
While	  preparing	  the	  kidney	  cortex	  samples	  for	  mitochondria	  purification,	  we	  saved	  
samples	  of	  the	  cortex	  for	  transmission	  electron	  microscopy	  in	  order	  to	  visualize	  changes	  
in	  mitochondria	  morphology	  in	  control	  and	  treatment	  groups.	  Normal	  mitochondria	  are	  
characterized	  by	  regular	  shape,	  dense	  matrix	  and	  parallel	  cristae[173].	  Mitochondria	  
injury	  can	  be	  visualized	  by	  changes	  in	  shape,	  number	  or	  size	  of	  mitochondria,	  changes	  in	  
density	  of	  matrix	  and	  increased	  space	  among	  cristae,	  or	  swelling	  of	  the	  mitochondria.	  
Through	  TEM,	  we	  are	  observing	  the	  degree	  of	  injury	  in	  each	  treatment	  group	  and	  the	  
associated	  morphological	  changes	  associated	  with	  each	  treatment,	  which	  can	  allow	  us	  
to	  speculate	  on	  possible	  mechanisms	  behind	  mitochondrial	  adaptations	  to	  injury.	  
	  
The	  following	  images	  are	  preliminary	  images	  from	  a	  few	  groups	  in	  the	  
preconditioned	  and	  injection	  study	  groups,	  and	  thus	  conclusions	  cannot	  yet	  be	  drawn	  
about	  the	  relationship	  between	  each	  treatment	  and	  the	  mitochondrial	  morphological	  
changes	  associated.	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Figure	  23:	  TEM	  image	  of	  Sham	  Sham	  rat	  kidney	  cortex.	  
The	  mitochondria	  of	  the	  sham	  sham	  samples	  appear	  normal,	  with	  regular	  shape,	  dense	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Figure	  24:	  TEM	  image	  of	  PC	  Uni	  rat	  kidney	  cortex.	  
Mitochondria	  appear	  generally	  regular,	  with	  more	  healthy	  appearing	  mitochondria	  than	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Figure	  25:	  TEM	  image	  of	  SI	  Uni	  rat	  kidney	  cortex.	  
There	  is	  a	  lack	  of	  brush	  borders	  and	  not	  many	  recognizable	  structures.	  Morphology	  is	  
drastically	  altered,	  with	  a	  lack	  of	  cristae	  in	  the	  mitochondria.	  Proximal	  and	  distal	  tubules	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Figure	  26:	  TEM	  image	  of	  Vehicle	  without	  injury	  rat	  kidney	  cortex.	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Figure	  27:	  TEM	  image	  of	  IDH2	  injected	  rat	  kidney	  cortex.	  
Mitochondria	  appear	  significantly	  more	  swollen	  than	  vehicle	  injected	  rats	  with	  
abnormal	  cristae.	  Unidentified	  black	  deposits	  also	  appear	  throughout	  the	  sample.	  
MT	  –	  Mitochondria.	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4.1 Summary	  of	  Results	  
In	  previous	  studies	  performed	  by	  Dr.	  Peter	  Corridon	  in	  the	  Atkinson	  lab,	  the	  
efficiency	  of	  hydrodynamic	  plasmid	  delivery	  was	  tested	  using	  fluorescent	  plasmid	  
vectors	  to	  the	  rat	  kidney.	  In	  ischemic	  preconditioning	  studies,	  the	  mitochondrial	  
proteins	  IDH2	  and	  SULT1C2	  were	  identified	  as	  upregulated	  in	  preconditioned	  without	  
second	  injury	  rats	  as	  compared	  to	  sham	  rats,	  and	  preconditioning	  conferred	  a	  resistance	  
to	  kidneys	  from	  subsequent	  insult.	  The	  delivery	  of	  eGFP,	  IDH2	  and	  SULT1C2	  were	  
confirmed	  via	  confocal	  and	  two	  photon	  imaging	  (eGFP)	  or	  western	  blot	  (IDH2	  and	  
SULT1C2),	  showing	  that	  the	  hydrodynamic	  fluid	  injections	  facilitated	  the	  delivery	  of	  
transgene	  to	  target	  cells	  in	  the	  rat	  kidney.	  Both	  preconditioned	  and	  IDH2	  plasmid	  
injected	  rats	  demonstrated	  resistance	  to	  further	  insults	  in	  the	  form	  of	  IRI,	  as	  shown	  in	  
serum	  creatinine	  measurements.	  	  
	  
Thus,	  we	  are	  trying	  to	  discern	  the	  function	  of	  the	  preconditioning	  effect	  via	  injection	  
of	  IDH2	  and	  mitochondria	  oxygen	  consumption	  in	  both	  preconditioned	  and	  IDH2	  rats.	  
Since	  IDH2	  protein	  is	  upregulated	  in	  a	  preconditioned	  without	  second	  injury	  kidney	  as	  
compared	  to	  a	  control,	  conferring	  protection	  onto	  the	  kidney	  against	  subsequent	  IRI	  as	  
seen	  in	  serum	  creatinine	  values,	  we	  performed	  in	  vitro	  assays	  of	  mitochondria	  oxygen	  
consumption	  on	  IDH2	  injected	  and	  preconditioned	  kidneys.	  As	  an	  essential	  enzyme	  in	  
the	  citric	  acid	  cycle,	  IDH2	  functions	  to	  modify	  mitochondria	  oxygen	  consumption.	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All	  mitochondria	  respiration	  data	  has	  been	  displayed	  on	  a	  logarithmic	  scale,	  as	  there	  
is	  large	  variability	  when	  our	  respiration	  values	  are	  large,	  and	  smaller	  variability	  when	  
our	  respiration	  values	  are	  smaller,	  which	  corresponds	  to	  data	  fitting	  a	  logarithmic	  scale.	  
	  
	  
4.2 The	  Implications	  of	  ischemia	  reperfusions	  injuries	  on	  rat	  kidneys	  and	  its	  effect	  on	  
mitochondria	  respiration.	  
Our	  hypothesis	  is	  that	  upregulated	  expression	  of	  IDH2,	  either	  through	  
preconditioning,	  or	  hydrodynamically	  delivered	  exogenous	  IDH2	  plasmids,	  will	  protect	  
renal	  function	  from	  subsequent	  insults	  by	  enhancing	  mitochondrial	  respiration.	  The	  
increased	  expression	  of	  IDH2	  may	  enhance	  certain	  pathways	  involved	  in	  mitochondria	  
respiration	  such	  as	  the	  TCA	  cycle,	  electron	  transport	  chain	  and	  oxidative	  
phosphorylation,	  and	  improve	  or	  maintain	  cell	  function	  against	  AKI.	  In	  our	  studies,	  the	  
two	  pronged	  effort	  to	  perform	  mitochondria	  oxygen	  consumption	  assays	  on	  
preconditioned	  groups	  and	  injection	  groups	  can	  help	  us	  discern	  the	  pathway	  through	  
which	  the	  preconditioning	  confers	  protection	  and	  use	  the	  knowledge	  derived	  from	  
these	  experiments	  to	  mimic	  the	  protective	  effect	  of	  preconditioning,	  while	  avoiding	  the	  
unacceptable	  clinical	  risks	  of	  ischemia	  reperfusion.	  	  
	  
According	  to	  our	  data	  from	  the	  comparison	  of	  control	  group	  to	  our	  sham	  unilateral	  
injury	  group	  (SI	  Uni),	  the	  insult	  to	  the	  left	  kidney	  resulted	  in	  depressed	  mitochondria	  
respiration	  rates	  and	  decreased	  levels	  of	  IDH2	  in	  the	  left	  kidney	  according	  to	  western	  
blot	  (the	  right	  kidney	  data	  is	  not	  included).	  In	  contrast,	  according	  to	  our	  data	  comparing	  
control	  group	  to	  sham	  bilateral	  injury	  group	  (SI	  Bi),	  for	  all	  three	  substrates,	  bilateral	  
injury	  resulted	  in	  increased	  mitochondria	  respiration	  rates	  and	  increased	  levels	  of	  IDH2	  
according	  to	  western	  blot	  analysis.	  	  This	  is	  consistent	  with	  increased	  levels	  of	  IDH2	  
contributing	  to	  increased	  respiration	  rates.	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The	  different	  effects	  of	  unilateral	  versus	  bilateral	  injury	  on	  both	  respiration	  and	  IDH2	  
levels	  are	  surprising.	  Unilateral	  ischemic	  injury	  (without	  preconditioning)	  results	  in	  
depressed	  mitochondria	  respiration	  rates	  but,	  if	  there	  is	  bilateral	  ischemic	  injury,	  the	  
recovery	  process	  in	  the	  mitochondria	  during	  reperfusion	  is	  drastically	  different	  from	  
when	  only	  one	  kidney	  is	  injured.	  When	  only	  one	  kidney	  is	  injured,	  there	  could	  be	  
neurohormonal	  mechanisms	  in	  place	  that	  signal	  to	  contralateral	  kidney	  to	  compensate	  
for	  the	  ischemic	  insult	  to	  the	  left	  kidney.	  In	  septic	  sheep	  kidneys,	  blood	  flow	  to	  the	  
contralateral	  kidney	  is	  significantly	  elevated	  resulting	  from	  increased	  sympathetic	  
nervous	  response	  in	  both	  the	  heart	  and	  the	  kidneys[79].	  	  
	  
The	  SI	  Bi	  group	  tells	  a	  story	  different	  from	  SI	  Uni	  group	  about	  the	  injury	  process	  when	  
the	  renal	  system	  is	  entirely	  impaired.	  Mitochondria	  respiration	  rates	  for	  SI	  Bi	  are	  
significantly	  higher	  than	  the	  control	  group,	  with	  correlating	  higher	  IDH2	  protein	  levels	  as	  
well.	  It	  suggests	  that	  when	  both	  kidneys	  are	  injured,	  during	  reperfusion,	  there	  are	  
processes	  at	  work	  during	  respiration	  that	  ramp	  up	  respiration	  rates,	  possibly	  through	  
the	  increased	  IDH2	  protein	  levels,	  which	  could	  be	  the	  driving	  force	  behind	  the	  increased	  
runs	  of	  TCA	  cycle.	  	  
	  
When	  only	  one	  kidney	  is	  injured,	  during	  reperfusion	  there	  could	  be	  processes	  at	  work	  
that	  allows	  for	  a	  different	  recovery	  process;	  the	  mitochondria	  might	  be	  diverting	  
resources	  to	  re-­‐equilibrating	  membrane	  potentials,	  restoring	  proton	  and	  ion	  
concentrations	  across	  membranes,	  repairing	  electron	  transport	  chain	  complexes,	  or	  
metabolizing	  the	  build	  up	  of	  ROS[93,	  110-­‐112,	  116,	  117].	  Or,	  due	  to	  diversion	  of	  blood	  
flow	  to	  the	  contralateral	  kidney	  from	  sympathetic	  nervous	  system	  responses,	  the	  
decreased	  blood	  flow	  to	  the	  left	  kidney	  could	  further	  impair	  the	  recovery	  process	  in	  the	  
left	  kidney,	  resulting	  in	  significantly	  depressed	  respiration	  rates	  in	  the	  SI	  Uni	  kidney.	  
Although	  a	  reliable	  conclusion	  cannot	  be	  drawn	  yet	  from	  the	  electron	  microscopy	  
images,	  the	  drastic	  damage	  to	  SI	  Uni	  mitochondria	  suggests	  that	  it	  is	  probably	  due	  to	  
the	  later	  situation,	  where	  blood	  flow	  is	  diverted	  to	  the	  right	  kidney	  during	  the	  recovery	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process.	  In	  SI	  Bi	  kidneys,	  there	  could	  be	  a	  more	  equal	  divide	  in	  blood	  flow	  during	  
reperfusion	  as	  the	  system	  detects	  that	  both	  kidneys	  are	  injured,	  resulting	  in	  improved	  
recovery	  in	  the	  reperfusion	  period.	  Also,	  with	  a	  40	  minute	  ischemia	  and	  1	  hour	  
reperfusion,	  the	  1	  hour	  reperfusion	  time	  shows	  the	  quick	  elevation	  in	  IDH2	  protein	  
levels	  and	  thus	  shows	  the	  quick	  response	  in	  the	  preconditioning	  event.	  	  
	  
A	  literature	  review	  revealed	  that	  many	  ischemic	  reperfusion	  studies	  are	  usually	  done	  
bilaterally	  [71,	  75,	  79,	  90,	  174-­‐176]or	  unilaterally	  with	  a	  previous	  nephrectomy	  on	  the	  
right	  kidney[177,	  178].	  	  In	  studies	  where	  unilateral	  injuries	  are	  performed	  without	  a	  
contralateral	  nephrectomy,	  contralateral	  kidney	  data	  are	  generally	  grouped	  with	  sham	  
controls,	  with	  no	  notable	  comment	  on	  distinctions	  found	  between	  them[58].	  	  
	  
	  
4.3 The	  Implications	  of	  preconditioning	  on	  rat	  kidneys	  and	  its	  effect	  on	  mitochondria	  
respiration.	  
	   According	  to	  our	  data,	  most	  of	  the	  preconditioned	  and	  subsequently	  unilaterally	  
or	  bilaterally	  injured	  rat	  renal	  mitochondria	  (PC	  Bi	  or	  PC	  Uni)	  respire	  at	  a	  rate	  similar	  
(p>0.05)	  or	  better	  (pyruvate:	  SS	  versus	  PC	  Bi,	  p<0.05)	  to	  our	  control	  group	  (SS)	  for	  two	  
substrates,	  succinate	  and	  pyruvate,	  but	  not	  for	  isocitrate:	  SS	  versus	  PC	  Uni	  (p<0.05).	  This	  
trend	  is	  similar	  to	  our	  findings	  from	  the	  injection	  groups,	  where	  IDH2	  injected	  and	  
subsequently	  injured	  renal	  mitochondria	  respires	  at	  a	  similar	  rate	  (p>0.05)	  to	  the	  saline	  
delivered,	  non-­‐injured	  group.	  The	  findings	  of	  generally	  non-­‐depressed	  mitochondria	  
respiration	  rates	  of	  PC	  Uni	  and	  PC	  bi	  groups	  support	  the	  previous	  findings,	  when	  serum	  
creatinine	  values	  of	  PC	  rats	  remain	  low	  even	  after	  a	  second	  insult	  compared	  to	  rats	  
which	  have	  not	  undergone	  preconditioning,	  and	  shows	  that	  the	  protection	  conferred	  by	  
preconditioning	  extends	  to	  mitochondrial	  function.	  	  
	  
However,	  the	  western	  blot	  analysis	  of	  IDH2	  protein	  levels	  show	  depressed	  levels	  
of	  IDH2	  for	  both	  PC	  Uni	  and	  PC	  Bi	  groups	  compared	  to	  controls,	  and	  similar	  to	  levels	  of	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SI	  Uni	  groups.	  This	  result	  differs	  from	  our	  expectation	  that	  IDH2	  levels	  would	  correlate	  
with	  mitochondrial	  respiration,	  and	  suggests	  that	  preconditioning	  may	  be	  able	  to	  confer	  
protection	  on	  mitochondrial	  function	  by	  other	  mechanism.	  	  
	  
	   If	  we	  were	  to	  take	  each	  treatment	  group	  and	  amalgamate	  the	  data	  into	  one	  
timeline,	  there	  are	  some	  conclusions	  to	  be	  drawn	  about	  the	  level	  of	  respiration	  and	  the	  
level	  of	  IDH2	  level.	  It	  is	  particularly	  notable	  that	  there	  are	  distinct	  responses	  in	  terms	  of	  
respiratory	  rate	  and	  IDH2	  levels	  to	  an	  initial	  bilateral	  injury	  versus	  a	  second	  injury	  to	  the	  
same	  kidney.	  Following	  the	  first	  IRI	  event,	  as	  illustrated	  in	  the	  SI	  Bi	  group,	  after	  one	  hour	  
reperfusion	  subsequent	  to	  a	  moderate	  ischemic	  injury,	  both	  kidneys	  are	  respiring	  at	  
higher	  rates	  than	  controls	  and	  IDH2	  protein	  levels	  are	  increased.	  The	  increased	  IDH2	  
protein	  levels	  could	  be	  possibly	  due	  to	  increased	  gene	  expression	  in	  response	  to	  the	  
injury,	  and	  rat	  renal	  mitochondria	  is	  ramping	  up	  respiration	  to	  compensate	  for	  the	  
injury.	  	  
	  
	   In	  the	  days	  after	  the	  first	  IRI,	  or	  the	  preconditioning	  event,	  both	  kidneys	  recover	  
as	  serum	  creatinine	  levels	  return	  to	  baseline	  levels.	  When	  there	  is	  a	  second	  IRI,	  
represented	  by	  the	  values	  from	  the	  PC	  Bi	  group,	  and	  in	  contrast	  to	  the	  events	  after	  the	  
first	  injury,	  IDH2	  protein	  levels	  are	  depressed,	  but	  the	  mitochondria	  have	  adapted	  to	  the	  
injury	  and	  are	  possibly	  able	  to	  respire	  at	  higher	  efficiency	  than	  previously	  due	  to	  the	  
adaptations	  from	  the	  first	  IRI	  event,	  but	  without	  the	  assistance	  of	  increased	  IDH2	  levels.	  
With	  depressed	  IDH2	  levels,	  there	  could	  be	  fewer	  cycles	  of	  the	  TCA	  cycles	  but	  each	  
electron	  carrier	  and	  electron	  carried	  through	  the	  ETC	  could	  be	  carried	  more	  efficiently.	  
For	  the	  substrates	  isocitrate	  and	  succinate,	  PC	  Bi	  respired	  at	  a	  level	  similar	  to	  SS	  controls	  
but	  pyruvate	  respired	  significantly	  better	  than	  SS	  controls.	  Since	  pyruvate	  is	  involved	  at	  
the	  beginning	  of	  the	  TCA	  cycle	  as	  a	  3-­‐carbon	  precursor,	  increased	  pyruvate	  
concentrations	  in	  the	  respiration	  chamber	  could	  be	  driving	  force	  behind	  pushing	  the	  
TCA	  cycle	  forward.	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4.4 Hydrodynamic	  fluid	  injections	  of	  IDH2	  plasmids	  partially	  mimics	  the	  preconditioning	  
effect	  
Our	  data	  from	  hydrodynamic	  fluid	  injections	  of	  IDH2	  plasmids,	  obtained	  from	  
Shijun	  Zhang’s	  thesis[172],	  shows	  improved	  mitochondria	  respiration	  rates	  for	  IDH2	  
groups	  compared	  to	  vehicle	  injury	  groups	  (VI)	  for	  the	  substrates	  of	  pyruvate	  and	  
succinate	  (p<0.05)	  but	  not	  for	  isocitrate.	  The	  IDH2	  injection	  groups	  also	  show	  similar	  
levels	  of	  respiration	  compared	  to	  the	  vehicle	  without	  injury	  control	  groups	  (VwoI).	  
Levels	  of	  IDH2	  protein	  in	  the	  IDH2	  injection	  group	  are	  elevated	  post-­‐IRI	  according	  to	  
western	  blot	  analysis.	  Comparison	  of	  the	  injection	  groups	  to	  the	  preconditioning	  groups	  
can	  yield	  information	  on	  the	  mechanism	  of	  preconditioning,	  recovery	  from	  an	  IRI	  and	  
the	  hydrodynamic	  injection	  treatment.	  	  
	  
The	  vehicle	  with	  injury	  group	  showed	  significantly	  depressed	  mitochondria	  
respiration	  rates,	  which	  is	  reasonable	  considering	  there	  could	  be	  minor	  injury	  to	  the	  
kidney	  following	  the	  injection	  (previous	  studies	  found	  that	  the	  injury	  is	  not	  significant	  
with	  normal	  serum	  creatinine	  values),	  and	  a	  moderate	  IRI	  prior	  to	  sacrifice.	  IDH2	  
injected	  mitochondria	  showed	  significantly	  improved	  respiration	  rates,	  showing	  that	  the	  
hydrodynamic	  injections	  of	  IDH2	  plasmids	  do	  protect	  the	  kidney	  from	  IRI.	  The	  SI	  Uni	  
data	  points	  are	  also	  allowing	  us	  to	  glean	  information	  about	  our	  injection	  models,	  as	  the	  
right	  kidneys	  are	  always	  shams,	  even	  in	  a	  VI	  and	  IDH2	  groups.	  When	  we	  compare	  the	  
IDH2	  group,	  which	  is	  unilaterally	  injured	  7	  days	  after	  a	  hydrodynamic	  fluid	  injection,	  to	  
the	  PC	  uni	  and	  SI	  Uni	  across	  substrates,	  the	  IDH2	  group	  respires	  more	  similar	  to	  the	  SI	  
uni	  group	  than	  the	  PC	  uni	  group.	  	  
	  
	   However,	  the	  IDH2	  injected	  group	  has	  elevated	  IDH2	  levels	  similar	  to	  the	  SI	  Bi	  
group,	  which	  shows	  that	  there	  could	  be	  some	  similarity	  between	  those	  groups	  in	  terms	  
of	  protein	  expression.	  And	  since	  mitochondria	  respiration	  levels	  are	  attenuated	  in	  the	  
IDH2	  injected	  kidneys	  after	  IRI,	  to	  the	  level	  of	  vehicle	  controls	  but	  not	  to	  the	  level	  of	  
sham	  controls,	  there	  is	  some	  level	  of	  protection	  in	  the	  IDH2	  injected	  kidneys	  conferred	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by	  the	  injection.	  The	  level	  of	  protection	  is	  not	  yet	  up	  to	  the	  sham	  controls,	  and	  thus	  
there	  is	  only	  partial	  protection	  conferred	  by	  the	  injection.	  	  
	  
The	  TEM	  images	  of	  the	  various	  preconditioning	  study	  and	  injection	  groups	  show	  the	  
various	  morphological	  changes	  that	  happen	  when	  the	  kidney	  is	  manipulated.	  The	  SI	  Uni	  
image	  shows	  one	  extreme	  end	  of	  injury,	  which	  correlates	  with	  the	  depressed	  
mitochondria	  respiration	  rates,	  with	  the	  loss	  of	  brush	  border	  and	  drastic	  morphological	  
changes.	  The	  preconditioned	  kidneys,	  even	  with	  two	  injuries	  within	  two	  weeks,	  has	  
more	  normal	  looking	  mitochondria	  than	  the	  SI	  Uni	  samples,	  which	  also	  corroborates	  
with	  the	  normal	  mitochondria	  respiration	  rates,	  however	  it	  is	  still	  morphologically	  
distinct	  from	  control	  SS	  kidney	  cortexes.	  The	  injection	  groups	  show	  that	  injections	  result	  
in	  swollen	  mitochondria	  as	  seen	  in	  the	  enlarged	  spaces	  in	  between	  cristae,	  which	  is	  
morphologically	  distinct	  from	  the	  SI	  Uni	  and	  PC	  Uni	  samples,	  suggesting	  an	  injury	  that	  is	  
distinct	  from	  the	  preconditioning	  injury	  groups.	  
	  
	  
4.5 The	  mitochondria	  respiration	  assay	  can	  be	  further	  improved	  to	  provide	  more	  
reliable	  and	  precise	  results	  
	   In	  our	  buffer	  comparison,	  EGTA	  as	  an	  ingredient	  in	  Terzic	  buffer	  for	  the	  
mitochondria	  respiration	  assay	  in	  place	  of	  EDTA	  lead	  to	  improved	  respiration	  rates	  for	  
the	  substrate	  succinate,	  and	  to	  a	  lesser	  extent,	  pyruvate.	  EGTA	  has	  more	  specific	  
calcium-­‐chelating	  properties	  and	  is	  also	  less	  specific	  for	  Mg2+	  ions,	  an	  important	  cofactor	  
in	  the	  TCA	  cycle,	  and	  this	  could	  be	  the	  reason	  for	  improved	  mitochondria	  respiration.	  	  
	  
	   Another	  improvement	  to	  the	  mitochondria	  respiration	  assay	  is	  reduced	  
quantities	  of	  substrate	  and	  ADP	  added	  to	  the	  mitochondria	  respiration	  chamber.	  We	  are	  
unable	  to	  calculate	  a	  respiration	  control	  index	  (RCI),	  which	  is	  a	  ratio	  of	  state	  III	  (oxygen	  
respiration)	  to	  state	  IV	  respiration	  (state	  of	  ADP	  depletion).	  The	  ratio	  represents	  a	  
quantification	  of	  mitochondria	  coupling	  and	  the	  higher	  the	  ratio,	  the	  tighter	  the	  
	   77	  
coupling	  between	  the	  mitochondrial	  respiratory	  chain	  and	  oxidative	  phosphorylation,	  
and	  is	  thus	  an	  important	  quantification	  of	  the	  quality	  of	  the	  respiration	  assay	  and	  
purification	  process.	  In	  our	  studies,	  the	  chamber	  ran	  out	  of	  oxygen	  before	  it	  could	  reach	  
state	  IV,	  a	  state	  of	  ADP	  depletion,	  and	  thus	  we	  could	  not	  calculate	  RCI.	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First,	  our	  lab	  performed	  studies	  to	  confirm	  that	  hydrodynamic	  fluid	  delivery	  could	  
efficiently	  delivery	  with	  stable	  expression	  of	  plasmid	  vectors	  into	  live	  rodent	  kidneys.	  
We	  used	  fluorescent	  plasmid	  EGFP-­‐actin	  delivered	  by	  hydrodynamic	  fluid	  renal	  
injection,	  and	  observed	  widespread	  expression	  with	  localization	  to	  cells	  of	  interest.	  The	  
technique	  was	  fine-­‐tuned	  through	  trial	  and	  error	  with	  various	  sites	  of	  injection	  before	  
narrowing	  down	  to	  renal	  artery	  and	  vein	  clamps,	  with	  a	  renal	  vein	  injection	  to	  optimize	  
delivery.	  	  
	  
At	  the	  same	  time,	  preconditioning	  studies	  conducted	  by	  the	  Basile	  lab	  showed	  the	  
preconditioning	  effect	  on	  the	  kidneys,	  where	  rats	  with	  preconditioned,	  or	  endured	  a	  
first	  ischemic	  reperfusion	  injury,	  were	  protected	  from	  a	  subsequent	  injury,	  as	  evaluated	  
by	  serum	  creatinine	  levels.	  Via	  proteomic	  analysis,	  we	  identified	  IDH2	  and	  SULT1C2	  as	  
potential	  targets	  for	  hydrodynamic	  plasmid	  fluid	  delivery	  to	  the	  kidneys	  of	  live	  Sprague	  
Dawley	  rats.	  In	  preliminary	  studies,	  via	  in	  situ	  PCR,	  amplified	  expression	  of	  the	  plasmids	  
was	  observed	  in	  the	  tissue	  sections	  of	  kidneys	  and	  via	  immune	  blot,	  the	  overexpression	  
of	  IDH2	  and	  SULT1C2	  through	  hydrodynamic	  plasmid	  delivery	  was	  also	  observed.	  	  
	  
We	  then	  turned	  our	  attention	  to	  functional	  assays.	  Through	  TMRM	  fluorescent	  
imaging,	  we	  observed	  that	  differences	  in	  mitochondria	  potential	  across	  preconditioned	  
and	  hydrodynamic	  plasmid	  delivered	  rats,	  and	  also	  IDH2	  and	  SULT1C2	  are	  enzymes	  in	  
the	  mitochondria,	  we	  performed	  mitochondria	  oxygen	  assays	  on	  preconditioned	  and	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IDH2-­‐injected	  rats	  to	  discern	  and	  elucidate	  the	  pathway	  through	  which	  the	  
preconditioning	  effect	  is	  conferring	  protection	  against	  acute	  kidney	  injury.	  	  
	  
In	  our	  studies	  with	  hydrodynamically	  IDH2	  injected	  rats,	  we	  observed	  that	  the	  
respiration	  rates	  for	  IDH2,	  injured	  kidneys	  are	  similar	  to	  vehicle	  injected,	  uninjured	  
kidneys,	  showing	  that	  upregulated	  IDH2	  does	  confer	  a	  protection	  on	  injured	  kidneys,	  
similar	  to	  the	  preconditioning	  effect.	  The	  hydrodynamic	  fluid	  delivery	  of	  IDH2	  can	  lessen	  
the	  assault	  on	  mitochondria	  dysfunction	  done	  by	  a	  moderate	  acute	  kidney	  injury.	  
Through	  mitochondria	  respirations	  with	  the	  substrates	  succinate	  and	  pyruvate,	  we	  
observed	  no	  differences	  between	  IDH2	  injured	  kidneys	  and	  vehicle	  uninjured	  kidneys.	  
Interestingly,	  even	  though	  IDH2	  is	  an	  isocitrate	  dehydrogenase,	  an	  important	  enzyme	  in	  
the	  electron	  transport	  chain,	  renal	  samples	  in	  the	  mitochondria	  respiration	  assays	  ran	  
with	  isocitrate	  showed	  no	  different	  between	  the	  IDH2	  injured	  kidneys	  and	  vehicle	  
injured	  kidneys,	  showing	  that	  the	  upregulation	  of	  IDH2	  does	  not	  upregulate	  oxygen	  
consumption	  in	  the	  mitochondria.	  
	  
In	  our	  studies	  with	  preconditioned	  rats,	  we	  observed	  that	  the	  respiration	  rates	  of	  
preconditioned,	  and	  subsequently	  injured,	  either	  bilaterally	  or	  unilaterally,	  are	  similar	  to	  
those	  of	  sham	  kidneys.	  This	  supports	  the	  previous	  study,	  where	  serum	  creatinine	  was	  
evaluated	  for	  the	  level	  of	  injury	  and	  protection.	  Interestingly,	  for	  our	  sham	  and	  
subsequently	  injured	  bilaterally	  kidneys,	  the	  respiration	  rate	  was	  higher	  than	  the	  sham,	  
which	  could	  provide	  a	  snapshot	  of	  the	  preconditioning	  effect,	  as	  the	  injury	  event	  is	  the	  
first	  insult	  to	  the	  kidney.	  However,	  the	  respiration	  rate	  for	  sham	  and	  subsequently	  
unilaterally	  kidneys	  was	  similar	  to	  vehicle	  injured	  (unilateral).	  Since	  the	  IDH2	  injections	  
are	  a	  unilateral	  injection	  and	  the	  subsequent	  injury	  to	  IDH2	  injected	  or	  vehicle	  injected	  
rats	  are	  unilateral,	  the	  depressed	  oxygen	  respiration	  rate	  for	  sham	  unilaterally	  injured	  
rats	  and	  vehicle	  with	  second	  injury	  rates	  as	  compared	  to	  the	  normal	  oxygen	  respiration	  
rate	  for	  IDH2	  injected,	  injured	  rats	  show	  that	  IDH2	  injections	  do	  confer	  protection	  onto	  
the	  kidneys.	  The	  sham,	  bilaterally	  injured	  rats	  kidneys	  respire	  better	  than	  sham,	  which	  is	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unexpected,	  but	  in	  our	  serum	  creatinine	  studies,	  serum	  creatinine	  is	  taken	  24	  hours	  post	  
injury,	  whereas	  the	  mitochondria	  assay	  is	  performed	  1	  hour	  post	  injury	  and	  start	  of	  
reperfusion,	  suggesting	  that	  during	  this	  one	  hour,	  there	  are	  mitochondria	  adaptations	  to	  
injury,	  but	  during	  the	  24	  hour	  period,	  kidney	  function	  does	  suffer,	  and	  by	  day	  14,	  when	  
there	  is	  subsequent	  insult,	  kidney	  mitochondria	  has	  adapted	  and	  can	  endure	  a	  
subsequent	  insult	  without	  sacrificing	  function.	  	  
	  
In	  conclusion,	  our	  studies	  have	  demonstrated	  efficient	  and	  effect	  hydrodynamic	  fluid	  
delivery	  of	  IDH2	  plasmids,	  which	  can	  partially	  mimic	  the	  preconditioning	  effect	  although	  
there	  can	  be	  no	  conclusions	  drawn	  yet	  as	  to	  whether	  it	  is	  the	  exact	  same	  pathway.	  
Further	  studies	  are	  needed	  to	  improve	  our	  mitochondria	  respiration	  assays,	  investigate	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There	  are	  numerous	  ways	  in	  which	  the	  data	  obtained	  in	  this	  study	  can	  be	  fine-­‐tuned.	  
The	  Oroborus	  and	  Seahorse	  machines	  are	  dramatically	  more	  precise	  and	  advanced	  
pieces	  of	  equipment	  that	  could	  hypothetically	  reduce	  the	  large	  error	  bars	  in	  the	  data.	  
The	  use	  of	  EGTA	  as	  an	  ingredient	  in	  the	  Terzic	  buffer	  can	  be	  another	  change	  as	  well	  that	  
will	  magnify	  the	  respiration	  rates	  of	  samples.	  We	  will	  continue	  to	  examine	  the	  
mitochondrial	  oxygen	  consumption	  study	  in	  preconditioning	  groups	  of	  Sprague	  Dawley	  
rats	  as	  well	  as	  hydrodynamic	  fluid	  delivery	  groups.	  Also,	  in	  the	  more	  advanced	  
machines,	  a	  respiratory	  control	  ratio	  (ratio	  of	  State	  III	  respiration	  to	  State	  IV	  respiration)	  
can	  be	  calculated.
	  
Our	  mitochondria	  purification	  can	  also	  be	  modified	  according	  to	  Shalbuyeva	  and	  
Brutoveksky[179].	  A	  looser	  fitting	  homogenizer	  can	  result	  in	  a	  higher	  yield	  of	  
mitochondria	  from	  the	  purification	  process.	  	  
	  
Our	  data	  shows	  that	  IDH2	  delivery	  does	  elevate	  mitochondrial	  oxygen	  consumption,	  
but	  not	  to	  the	  levels	  as	  shown	  in	  the	  early	  preconditioning	  phase,	  as	  represented	  by	  SI	  
Bi	  with	  its	  one	  hour	  of	  reperfusion.	  We	  have	  previously	  identified	  another	  target	  of	  gene	  
delivery,	  SULT1C2,	  and	  we	  could	  perform	  hydrodynamic	  injection	  studies	  on	  SULT1C2,	  
or	  a	  combination	  of	  IDH2	  and	  SULT1C2	  to	  mimic	  the	  full	  effect	  of	  preconditioning.	  Also,	  
in	  order	  to	  understand	  preconditioning,	  we	  still	  need	  to	  determine	  the	  role	  that	  IDH2	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